Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Statistician, Duke Clinical Research Institute, Duke University 1997 - 2002
  • Ph.D., North Carolina State University 2002
  • Data Analyst, Neurosurgery, University of Washington 1995 - 1997
  • Research Assistant, Biostatistics, University of North Carolina - Chapel Hill 1993 - 1995
  • M.S., University of North Carolina - Chapel Hill 1994
  • B.S., Cornell University 1992
• 

  Duke Appointment History

  • Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2018 - 2020
  • Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2011 - 2018
  • Assistant Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2007 - 2011
  • Assistant Research Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2002 - 2007
  • Instructor, Temporary of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2002
• 

  Leadership & Clinical Positions at Duke

  • Director, Biostatistics at the Duke Clinical Research Institute
• Recognition
• 

  In the News

  • APR 2, 2020

    Duke to Lead $50 Million Study of COVID-19 Prevention In Health Care Workers
• Research
• 

  Selected Grants

  • 2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC awarded by National Institutes of Health 2021 - 2026
  • Congestion Phenotypes and Splanchnic Nerve Modulation in Chronic Heart Failure awarded by National Institutes of Health 2020 - 2025
  • Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis awarded by National Institutes of Health 2020 - 2025
  • Postdoctoral Training in Cardiovascular Clinical Research awarded by National Institutes of Health 2003 - 2024
  • The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination awarded by National Institutes of Health 2018 - 2023
  • Ph3 ATTR Cardiomyopathy Study awarded by Eidos Therapeutics 2019 - 2023
  • HERO Program, HERO Registry, HERO-HCQ Trial awarded by Patient Centered Outcomes Research Institute 2020 - 2023
  • ACTIV-1 awarded by Technical Resources International 2020 - 2022
  • TRANSFORM-HF DCC awarded by National Institutes of Health 2017 - 2022
  • Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-Study (Yale Subaward) awarded by Yale University 2019 - 2022
  • SPIRRIT - DCC awarded by National Institutes of Health 2017 - 2022
  • Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center awarded by National Institutes of Health 2015 - 2022
  • ACTIV IV COVID-19 Post-hospital Thrombosis Prevention Study awarded by Research Triangle Institute International 2020 - 2021
  • The ISCHEMIA Trial - EQOL awarded by National Institutes of Health 2011 - 2021
  • Heart Failure Network: Year 12 Non-Compete Renewal awarded by National Institutes of Health 2006 - 2021
  • Integrated Biostatistical Training for CVD Research awarded by North Carolina State University 2017 - 2021
  • Metals in the Trial to Assess Chelation Therapy 2 (TACT2M) awarded by Mount Sinai Medical Center of Florida, Inc. 2016 - 2021
  • Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center awarded by National Institutes of Health 2015 - 2020
  • Lung Microbiome Study in IPF awarded by Weill Cornell Medicine 2019 - 2020
  • Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis - CleanUP-IPF awarded by Weill Cornell Medicine 2019 - 2020
  • Lung Microbiome Study in IPF awarded by Cornell University 2015 - 2020
  • HFN / HIV Supplement awarded by National Institutes of Health 2006 - 2019
  • Warfarin versus Direct Oral Anticoagulants for Secondary Prevention of Recurent Venous Thromboembolism awarded by Patient Centered Outcomes Research Institute 2017 - 2019
  • IPF Wrap awarded by University of California - San Francisco 2013 - 2017
  • GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC) awarded by National Institutes of Health 2012 - 2017
  • CABANA-AF Trial awarded by National Institutes of Health 2009 - 2017
  • Palliative Care in Heart Failure (PAL-HF) awarded by National Institutes of Health 2011 - 2016
  • Creating a Pulmonary Fibrosis Foundation Patient Registry and Care Center Network awarded by Pulmonary Fibrosis Foundation 2014 - 2015
  • PROMISE Trial: EQOL Coordinating Center awarded by National Institutes of Health 2009 - 2015
  • Idiopathic Pulmonary Fibrosis Clinical Research Network awarded by National Institutes of Health 2009 - 2014
  • Idiopathic Pulmonary Fibrosis Clinical Research Network awarded by National Institutes of Health 2005 - 2014
  • Idiopathic Pulmonary Fibrosis Clinical Research Network NCE awarded by National Institutes of Health 2005 - 2014
  • ICD Therapy in Patients with Congestive Heart Failure awarded by National Institutes of Health 2009 - 2014
  • Improving Methods for Comparative Effectiveness Research in Cardiovascular Care awarded by Agency for Healthcare Research and Quality 2008 - 2013
  • Novel Cellular Immune Profiles to Predict Lung Disease Outcomes awarded by National Institutes of Health 2011 - 2013
  • Improving Care Transitions for Complex Patients through Decision Support awarded by Agency for Healthcare Research and Quality 2008 - 2012
  • DEcIDE DES TO4 W3 awarded by Agency for Healthcare Research and Quality 2009 - 2012
  • DEcIDE Stents TO4 WA2 awarded by Agency for Healthcare Research and Quality 2009 - 2012
  • Heart Failure Clinical Research Network - DCC awarded by National Institutes of Health 2006 - 2011
  • Improving Quality through Decision Support for Evidence-Based Pharmacotherapy awarded by Agency for Healthcare Research and Quality 2007 - 2011
  • Enabling Personalized Medicine through Clinical Decision Support awarded by National Institutes of Health 2008 - 2011
  • Augmenting Healthcare through Patient Participation in a Rural Community-Based Telehealth Network awarded by Health Resources and Services Administration (HRSA) 2006 - 2010
  • Heart Failure : Epidemiology & Outcomes in the Elderly awarded by National Institutes of Health 2006 - 2009
  • Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions awarded by Agency for Healthcare Research and Quality 2008 - 2009
  • PEG-uricase as Therapy for Refractory Gout IND#11274 awarded by Food and Drug Administration 2004 - 2009
  • Showing Health Information Value in a Community Network awarded by Agency for Healthcare Research and Quality 2004 - 2008
  • DCRI Research Center for CERTs awarded by Agency for Healthcare Research and Quality 1999 - 2008
  • Improving Care Quality and Coordination through Patient Inclusion in a Community-based Telehealth Network awarded by Health Resources and Service Administration 2003 - 2007
  • Treatment of In-Stent Restenosis awarded by Agency for Healthcare Research and Quality 2005 - 2007
  • Determinants of Procedure Use in Myocardial Infarction awarded by National Institutes of Health 1999 - 2004
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Voors, Adriaan A., Hillary Mulder, Eugene Reyes, Martin R. Cowie, Johan Lassus, Adrian F. Hernandez, Justin A. Ezekowitz, et al. “Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial.” Eur J Heart Fail 23, no. 8 (August 2021): 1313–21. https://doi.org/10.1002/ejhf.2221.
       Full Text  Link to Item
    • Eisenstein, Eric L., Meredith N. Zozus, Sharon F. Terry, Linda Davidson-Ray, and Kevin J. Anstrom. “Ascertaining Nonfatal Endpoints in Clinical Trials: Central Adjudication Versus Patient Insurance Claims.” Ther Innov Regul Sci, July 6, 2021. https://doi.org/10.1007/s43441-021-00321-9.
       Full Text  Link to Item
    • Mentz, Robert J., Hillary Mulder, Arend Mosterd, Nancy K. Sweitzer, Michele Senni, Javed Butler, Justin A. Ezekowitz, et al. “Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.” J Card Fail, June 24, 2021. https://doi.org/10.1016/j.cardfail.2021.05.016.
       Full Text  Link to Item
    • Lam, Carolyn S. P., Anna Giczewska, Karen Sliwa, Frank Edelmann, Jens Refsgaard, Edimar Bocchi, Justin A. Ezekowitz, et al. “Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.” Jama Cardiol 6, no. 6 (June 1, 2021): 706–12. https://doi.org/10.1001/jamacardio.2020.6455.
       Full Text  Link to Item
    • Mentz, Robert J., Hillary Mulder, Arend Mosterd, Nancy K. Sweitzer, Michele Senni, Javed Butler, Justin A. Ezekowitz, et al. “Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model.” J Card Fail, May 26, 2021. https://doi.org/10.1016/j.cardfail.2021.05.016.
       Full Text  Link to Item
    • Martinez, Fernando J., Eric Yow, Kevin R. Flaherty, Laurie D. Snyder, Michael T. Durheim, Stephen R. Wisniewski, Frank C. Sciurba, et al. “Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.” Jama 325, no. 18 (May 11, 2021): 1841–51. https://doi.org/10.1001/jama.2021.4956.
       Full Text  Link to Item
    • Greene, Stephen J., Eric J. Velazquez, Kevin J. Anstrom, Eric L. Eisenstein, Shelly Sapp, Shelby Morgan, Tina Harding, et al. “Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.” Jacc Heart Fail 9, no. 5 (May 2021): 325–35. https://doi.org/10.1016/j.jchf.2021.01.013.
       Full Text  Link to Item
    • Wan, Luxi, Marc D. Samsky, Christopher M. O’Connor, Amanda Stebbins, Brooke Alhanti, Haider J. Warraich, Kimberly S. Johnson, et al. “Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire With a Palliative Care Intervention for Patients With Advanced Heart Failure: Insights from PAL-HF.” J Card Fail, February 26, 2021. https://doi.org/10.1016/j.cardfail.2021.02.007.
       Full Text  Link to Item
    • “Errors in Figure Labels.” Jama 325, no. 5 (February 2, 2021): 494–494. https://doi.org/10.1001/jama.2020.27059.
       Full Text
    • Chakraborty, H., N. Solomon, and K. J. Anstrom. “A method to estimate intra-cluster correlation for clustered categorical data.” Communications in Statistics  Theory and Methods, January 1, 2021. https://doi.org/10.1080/03610926.2021.1914660.
       Full Text
    • Gershon, Andrea S., Peter K. Lindenauer, Kevin C. Wilson, Louise Rose, Allan J. Walkey, Mohsen Sadatsafavi, Kevin J. Anstrom, et al. “Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.” Am J Respir Crit Care Med 203, no. 1 (January 1, 2021): 14–23. https://doi.org/10.1164/rccm.202010-3943ST.
       Full Text  Link to Item
    • Olsen, Cameron R., Robert J. Mentz, Kevin J. Anstrom, David Page, and Priyesh A. Patel. “Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure.” Am Heart J 229 (November 2020): 1–17. https://doi.org/10.1016/j.ahj.2020.07.009.
       Full Text  Link to Item
    • Armstrong, Paul W., Carolyn S. P. Lam, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor, Burkert Pieske, et al. “Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.” Jama 324, no. 15 (October 20, 2020): 1512–21. https://doi.org/10.1001/jama.2020.15922.
       Full Text  Link to Item
    • Armstrong, Paul W., Kevin J. Anstrom, Christopher M. O’Connor, and Christopher M. VICTORIA Study Group. “Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.” N Engl J Med 383, no. 15 (October 8, 2020): 1497–98. https://doi.org/10.1056/NEJMc2027731.
       Full Text  Link to Item
    • Jawitz, Oliver K., Tracy Y. Wang, Renato D. Lopes, Alma Chavez, Brittanny Boyer, Hwasoon Kim, Kevin J. Anstrom, et al. “Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.” Am Heart J 227 (September 2020): 91–99. https://doi.org/10.1016/j.ahj.2020.06.014.
       Full Text  Link to Item
    • Butler, Javed, Kevin J. Anstrom, and Paul W. Armstrong. “Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial.” Circulation 142, no. 8 (August 25, 2020): 717–19. https://doi.org/10.1161/CIRCULATIONAHA.120.047086.
       Full Text  Link to Item
    • Escolar, Esteban, Francisco Ujueta, Hwasoon Kim, Daniel B. Mark, Robin Boineau, Richard L. Nahin, Christine Goertz, Kerry L. Lee, Kevin J. Anstrom, and Gervasio A. Lamas. “Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).” J Diabetes Complications 34, no. 8 (August 2020): 107616. https://doi.org/10.1016/j.jdiacomp.2020.107616.
       Full Text  Link to Item
    • Poole, Jeanne E., Brian Olshansky, Daniel B. Mark, Jill Anderson, George Johnson, Anne S. Hellkamp, Linda Davidson-Ray, et al. “Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.” J Am Coll Cardiol 76, no. 4 (July 28, 2020): 405–15. https://doi.org/10.1016/j.jacc.2020.05.061.
       Full Text  Link to Item
    • Sendak, Mark P., William Ratliff, Dina Sarro, Elizabeth Alderton, Joseph Futoma, Michael Gao, Marshall Nichols, et al. “Real-World Integration of a Sepsis Deep Learning Technology Into Routine Clinical Care: Implementation Study.” Jmir Med Inform 8, no. 7 (July 15, 2020): e15182. https://doi.org/10.2196/15182.
       Full Text  Link to Item
    • Fiuzat, Mona, Justin Ezekowitz, Wendimagegn Alemayehu, Cynthia M. Westerhout, Marco Sbolli, Dario Cani, David J. Whellan, et al. “Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiol 5, no. 7 (July 1, 2020): 757–64. https://doi.org/10.1001/jamacardio.2020.0640.
       Full Text  Link to Item
    • Diepen, Sean van, Rajendra H. Mehta, Jeffrey D. Leimberger, Shaun G. Goodman, Stephen Fremes, Rachael Jankowich, Matthias Heringlake, et al. “Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.” J Thorac Cardiovasc Surg 159, no. 6 (June 2020): 2302-2309.e6. https://doi.org/10.1016/j.jtcvs.2019.06.020.
       Full Text  Link to Item
    • Armstrong, Paul W., Burkert Pieske, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Javed Butler, Carolyn S. P. Lam, et al. “Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.” N Engl J Med 382, no. 20 (May 14, 2020): 1883–93. https://doi.org/10.1056/NEJMoa1915928.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Christopher P. Cannon, Niteesh K. Choudhry, Timothy D. Henry, Kevin J. Anstrom, et al. “Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial.” Jama Cardiol 5, no. 5 (May 1, 2020): 532–39. https://doi.org/10.1001/jamacardio.2020.0125.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Kevin J. Anstrom, Gregg C. Fonarow, Timothy D. Henry, Christopher P. Cannon, et al. “Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.” Circ Cardiovasc Qual Outcomes 13, no. 5 (May 2020): e006182. https://doi.org/10.1161/CIRCOUTCOMES.119.006182.
       Full Text  Link to Item
    • Butler, Javed, Stephen J. Greene, Svati H. Shah, Sanjiv J. Shah, Kevin J. Anstrom, Raymond J. Kim, Andreas P. Kalogeropoulos, et al. “Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study.” J Card Fail 26, no. 5 (May 2020): 371–80. https://doi.org/10.1016/j.cardfail.2019.10.011.
       Full Text  Link to Item
    • Doll, Jacob A., Lisa A. Kaltenbach, Kevin J. Anstrom, Christopher P. Cannon, Timothy D. Henry, Gregg C. Fonarow, Niteesh K. Choudhry, et al. “Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs.” Journal of the American Heart Association 9, no. 8 (April 17, 2020): e014975. https://doi.org/10.1161/jaha.119.014975.
       Full Text
    • Anstrom, Kevin J., Imre Noth, Kevin R. Flaherty, Rex H. Edwards, Joan Albright, Amanda Baucom, Maria Brooks, et al. “Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.” Respir Res 21, no. 1 (March 12, 2020): 68. https://doi.org/10.1186/s12931-020-1326-1.
       Full Text  Link to Item
    • Fudim, Marat, Jacob P. Kelly, Aaron D. Jones, Omar F. AbouEzzeddine, Andrew P. Ambrosy, Stephen J. Greene, Yogesh N. V. Reddy, et al. “Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?” Am Heart J 220 (February 2020): 97–107. https://doi.org/10.1016/j.ahj.2019.11.006.
       Full Text  Link to Item
    • Cunningham, Jonathan W., Jie-Lena Sun, Finnian R. Mc Causland, Samantha Ly, Kevin J. Anstrom, Joann Lindenfeld, Michael M. Givertz, Lynne W. Stevenson, and Neal K. Lakdawala. “Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.” Clin Cardiol 43, no. 1 (January 2020): 43–49. https://doi.org/10.1002/clc.23286.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Christopher P. Cannon, Niteesh K. Choudhry, Timothy D. Henry, Kevin J. Anstrom, et al. “Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.” Jama Cardiol 5, no. 1 (January 1, 2020): 38–46. https://doi.org/10.1001/jamacardio.2019.4408.
       Full Text  Link to Item
    • Butler, Javed, Milton Packer, Stephen J. Greene, Mona Fiuzat, Stefan D. Anker, Kevin J. Anstrom, Peter E. Carson, et al. “Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.” Circulation 140, no. 25 (December 17, 2019): 2108–18. https://doi.org/10.1161/CIRCULATIONAHA.119.042155.
       Full Text  Link to Item
    • Pieske, Burkert, Mahesh J. Patel, Cynthia M. Westerhout, Kevin J. Anstrom, Javed Butler, Justin Ezekowitz, Adrian F. Hernandez, et al. “Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.” Eur J Heart Fail 21, no. 12 (December 2019): 1596–1604. https://doi.org/10.1002/ejhf.1664.
       Full Text  Link to Item
    • Januzzi, James L., Tariq Ahmad, Hillary Mulder, Adrian Coles, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, et al. “Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 74, no. 9 (September 3, 2019): 1205–17. https://doi.org/10.1016/j.jacc.2019.06.055.
       Full Text  Link to Item
    • Warraich, Haider J., Christopher M. O’Connor, Hongqiu Yang, Bradi B. Granger, Kimberly S. Johnson, Daniel B. Mark, Kevin J. Anstrom, et al. “African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial.” J Card Fail 25, no. 8 (August 2019): 693–94. https://doi.org/10.1016/j.cardfail.2019.05.013.
       Full Text  Link to Item
    • “Error in the Results.” Jama 321, no. 23 (June 18, 2019): 2370–2370. https://doi.org/10.1001/jama.2019.7682.
       Full Text
    • O’Connor, Christopher, Mona Fiuzat, Hillary Mulder, Adrian Coles, Tariq Ahmad, Justin A. Ezekowitz, Kirkwood F. Adams, et al. “Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.” Eur J Heart Fail 21, no. 6 (June 2019): 770–78. https://doi.org/10.1002/ejhf.1450.
       Full Text  Link to Item
    • Rao, Veena S., Tariq Ahmad, Meredith A. Brisco-Bacik, Joseph V. Bonventre, F Perry Wilson, Edward D. Siew, G Michael Felker, et al. “Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.” Circ Heart Fail 12, no. 6 (June 2019): e005552. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005552.
       Full Text  Link to Item
    • Butler, Javed, Carolyn S. P. Lam, Kevin J. Anstrom, Justin Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor, Burkert Pieske, et al. “Rationale and Design of the VITALITY-HFpEF Trial.” Circ Heart Fail 12, no. 5 (May 2019): e005998. https://doi.org/10.1161/CIRCHEARTFAILURE.119.005998.
       Full Text  Link to Item
    • Farrand, Erica, Kevin J. Anstrom, Gordon Bernard, Atul J. Butte, Carlos Iribarren, Brett Ley, Fernando J. Martinez, and Harold R. Collard. “Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.” Am J Respir Crit Care Med 199, no. 9 (May 1, 2019): 1061–65. https://doi.org/10.1164/rccm.201807-1209PP.
       Full Text  Link to Item
    • Steinberg, Benjamin A., Paul Dorian, Kevin J. Anstrom, Rachel Hess, Daniel B. Mark, Peter A. Noseworthy, John A. Spertus, and Jonathan P. Piccini. “Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis.” Jacc Clin Electrophysiol 5, no. 5 (May 2019): 599–605. https://doi.org/10.1016/j.jacep.2019.03.008.
       Full Text  Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Shubin Sheng, Jonathan P. Piccini, Khaula N. Baloch, Kristi H. Monahan, Melanie R. Daniels, et al. “Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.” Jama 321, no. 13 (April 2, 2019): 1275–85. https://doi.org/10.1001/jama.2019.0692.
       Full Text  Link to Item
    • Daubert, Melissa A., Kirkwood Adams, Eric Yow, Huiman X. Barnhart, Pamela S. Douglas, Susan Rimmer, Casey Norris, et al. “NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.” Jacc Heart Fail 7, no. 2 (February 2019): 158–68. https://doi.org/10.1016/j.jchf.2018.10.014.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kristi Prather, Stephen J. Greene, Tina Harding, Amanda Harrington, Davera Gabriel, Ingrid Jones, Robert J. Mentz, Eric J. Velazquez, and Kevin J. Anstrom. “Death: The Simple Clinical Trial Endpoint.” Stud Health Technol Inform 257 (2019): 86–91.
       Link to Item
    • Piccini, Jonathan P., Sean D. Pokorney, Kevin J. Anstrom, Olaf Oldenburg, Naresh M. Punjabi, Mona Fiuzat, Gudaye Tasissa, et al. “Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea.” Heart Rhythm 16, no. 1 (January 2019): 91–97. https://doi.org/10.1016/j.hrthm.2018.07.027.
       Full Text  Link to Item
    • Wang, Tracy Y., Lisa A. Kaltenbach, Christopher P. Cannon, Gregg C. Fonarow, Niteesh K. Choudhry, Timothy D. Henry, David J. Cohen, et al. “Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.” Jama 321, no. 1 (January 1, 2019): 44–55. https://doi.org/10.1001/jama.2018.19791.
       Full Text  Link to Item
    • Mark, Daniel B., Patricia A. Cowper, Kevin J. Anstrom, Shubin Sheng, Melanie R. Daniels, J David Knight, Khaula N. Baloch, et al. “Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.” J Am Coll Cardiol 72, no. 21 (November 27, 2018): 2551–62. https://doi.org/10.1016/j.jacc.2018.08.2184.
       Full Text  Link to Item
    • Borlaug, Barry A., Kevin J. Anstrom, Gregory D. Lewis, Sanjiv J. Shah, James A. Levine, Gabe A. Koepp, Michael M. Givertz, et al. “Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.” Jama 320, no. 17 (November 6, 2018): 1764–73. https://doi.org/10.1001/jama.2018.14852.
       Full Text  Link to Item
    • Palmer, Scott M., Laurie Snyder, Jamie L. Todd, Benjamin Soule, Rose Christian, Kevin Anstrom, Yi Luo, Robert Gagnon, and Glenn Rosen. “Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.” Chest 154, no. 5 (November 2018): 1061–69. https://doi.org/10.1016/j.chest.2018.08.1058.
       Full Text  Link to Item
    • Groarke, John D., Susanna R. Stevens, Robert J. Mentz, Lauren B. Cooper, Justin M. Vader, Omar F. AbouEzzeddine, Justin L. Grodin, et al. “Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure Hospitalization.” J Card Fail 24, no. 9 (September 2018): 542–49. https://doi.org/10.1016/j.cardfail.2017.12.013.
       Full Text  Link to Item
    • Raghu, Ganesh, Carlos A. Pellegrini, Eric Yow, Kevin R. Flaherty, Keith Meyer, Imre Noth, Mary Beth Scholand, et al. “Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.” Lancet Respir Med 6, no. 9 (September 2018): 707–14. https://doi.org/10.1016/S2213-2600(18)30301-1.
       Full Text  Link to Item
    • Daubert, Melissa A., David J. Whellan, Holger Woehrle, Gudaye Tasissa, Kevin J. Anstrom, JoAnn Lindenfeld, Adam Benjafield, et al. “Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial.” Am Heart J 201 (July 2018): 40–48. https://doi.org/10.1016/j.ahj.2018.03.026.
       Full Text  Link to Item
    • Kiernan, Michael S., Susanna R. Stevens, WH Wilson Tang, Javed Butler, Kevin J. Anstrom, Edo Y. Birati, Justin L. Grodin, et al. “Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.” J Card Fail 24, no. 7 (July 2018): 428–38. https://doi.org/10.1016/j.cardfail.2018.02.002.
       Full Text  Link to Item
    • Waldron, Nathan H., Mary Cooter, Jonathan P. Piccini, Kevin J. Anstrom, Rebecca Y. Klinger, Miklos D. Kertai, Mihai V. Podgoreanu, Mark Stafford-Smith, Mark F. Newman, and Joseph P. Mathew. “Predictive ability of perioperative atrial fibrillation risk indices in cardiac surgery patients: a retrospective cohort study.” Can J Anaesth 65, no. 7 (July 2018): 786–96. https://doi.org/10.1007/s12630-018-1119-x.
       Full Text  Link to Item
    • Abernethy, Abraham, Sadi Raza, Jie-Lena Sun, Kevin J. Anstrom, Russell Tracy, Johannes Steiner, Peter VanBuren, and Martin M. LeWinter. “Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.” J Am Heart Assoc 7, no. 8 (April 12, 2018). https://doi.org/10.1161/JAHA.117.007385.
       Full Text  Link to Item
    • Butler, Javed, Andreas P. Kalogeropoulos, Kevin J. Anstrom, Priscilla Y. Hsue, Raymond J. Kim, Rebecca Scherzer, Sanjiv J. Shah, et al. “Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study.” J Card Fail 24, no. 4 (April 2018): 255–65. https://doi.org/10.1016/j.cardfail.2018.02.001.
       Full Text  Link to Item
    • Rymer, Jennifer A., Lisa A. Kaltenbach, Kevin J. Anstrom, Gregg C. Fonarow, Nathaniel Erskine, Eric D. Peterson, and Tracy Y. Wang. “Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction.” Am Heart J 198 (April 2018): 97–107. https://doi.org/10.1016/j.ahj.2017.08.024.
       Full Text  Link to Item
    • Lugogo, Njira, Cynthia L. Green, Noah Agada, Siyi Zhang, Susanne Meghdadpour, Run Zhou, Siyun Yang, et al. “Obesity's effect on asthma extends to diagnostic criteria.” J Allergy Clin Immunol 141, no. 3 (March 2018): 1096–1104. https://doi.org/10.1016/j.jaci.2017.04.047.
       Full Text  Link to Item
    • Armstrong, Paul W., Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Javed Butler, Adriaan A. Voors, Carolyn S. P. Lam, et al. “A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.” Jacc Heart Fail 6, no. 2 (February 2018): 96–104. https://doi.org/10.1016/j.jchf.2017.08.013.
       Full Text  Link to Item
    • Butler, Javed, Kevin J. Anstrom, G Michael Felker, Michael M. Givertz, Andreas P. Kalogeropoulos, Marvin A. Konstam, Douglas L. Mann, et al. “Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial.” Jama Cardiol 2, no. 9 (September 1, 2017): 950–58. https://doi.org/10.1001/jamacardio.2017.2198.
       Full Text  Link to Item
    • Felker, G Michael, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L. Januzzi, et al. “Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” Jama 318, no. 8 (August 22, 2017): 713–20. https://doi.org/10.1001/jama.2017.10565.
       Full Text  Link to Item
    • Pericàs, J. M., J. A. Messina, C. Garcia-de-la-Mària, L. Park, B. K. Sharma-Kuinkel, F. Marco, D. Wray, et al. “Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.” Clin Microbiol Infect 23, no. 8 (August 2017): 544–49. https://doi.org/10.1016/j.cmi.2017.01.017.
       Full Text  Link to Item
    • Wang, Hanghang, Kevin Anstrom, Olga Ilkayeva, Michael J. Muehlbauer, James R. Bain, Steven McNulty, Christopher B. Newgard, et al. “Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial.” Jama Cardiol 2, no. 8 (August 1, 2017): 896–901. https://doi.org/10.1001/jamacardio.2017.1239.
       Full Text  Link to Item
    • Rogers, Joseph G., Chetan B. Patel, Robert J. Mentz, Bradi B. Granger, Karen E. Steinhauser, Mona Fiuzat, Patricia A. Adams, et al. “Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.” J Am Coll Cardiol 70, no. 3 (July 18, 2017): 331–41. https://doi.org/10.1016/j.jacc.2017.05.030.
       Full Text  Link to Item
    • Rogers, Joseph G., Chetan B. Patel, Robert J. Mentz, Bradi B. Granger, Karen E. Steinhauser, Mona Fiuzat, Patricia A. Adams, et al. “Palliative Care in Heart Failure The PAL-HF Randomized, Controlled Clinical Trial.” Journal of the American College of Cardiology 70, no. 3 (July 18, 2017): 332–41.
       Link to Item
    • Ambrosy, Andrew P., Ankeet S. Bhatt, Dianne Gallup, Kevin J. Anstrom, Javed Butler, Adam D. DeVore, G Michael Felker, et al. “Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).” Am J Cardiol 120, no. 1 (July 1, 2017): 98–105. https://doi.org/10.1016/j.amjcard.2017.03.249.
       Full Text  Link to Item
    • Guimarães, Patricia O., Arun Krishnamoorthy, Lisa A. Kaltenbach, Kevin J. Anstrom, Mark B. Effron, Daniel B. Mark, Patrick L. McCollam, Linda Davidson-Ray, Eric D. Peterson, and Tracy Y. Wang. “Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.” Jama Cardiol 2, no. 7 (July 1, 2017): 750–57. https://doi.org/10.1001/jamacardio.2017.1460.
       Full Text  Link to Item
    • Grodin, Justin L., Dianne Gallup, Kevin J. Anstrom, G Michael Felker, Horng H. Chen, and WH Wilson Tang. “Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).” Am J Cardiol 119, no. 12 (June 15, 2017): 2003–9. https://doi.org/10.1016/j.amjcard.2017.03.031.
       Full Text  Link to Item
    • Mehta, Rajendra H., Jeffrey D. Leimberger, Sean van Diepen, James Meza, Alice Wang, Rachael Jankowich, Robert W. Harrison, et al. “Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.” N Engl J Med 376, no. 21 (May 25, 2017): 2032–42. https://doi.org/10.1056/NEJMoa1616218.
       Full Text  Link to Item
    • Lewis, Gregory D., Rajeev Malhotra, Adrian F. Hernandez, Steven E. McNulty, Andrew Smith, G Michael Felker, WH Wilson Tang, et al. “Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.” Jama 317, no. 19 (May 16, 2017): 1958–66. https://doi.org/10.1001/jama.2017.5427.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Stefan K. James, Giora Weisz, Kristi Prather, Kevin J. Anstrom, Daniel B. Mark, Ori Ben-Yehuda, Karen P. Alexander, Gregg W. Stone, and E Magnus Ohman. “Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.” J Am Coll Cardiol 69, no. 18 (May 9, 2017): 2304–13. https://doi.org/10.1016/j.jacc.2017.02.056.
       Full Text  Link to Item
    • O’Connor, C. M., D. J. Whellan, M. Fiuzat, N. M. Punjabi, G. Tasissa, K. J. Anstrom, A. Benjafield, et al. “Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial (vol 69, pg 1577, 2017).” Journal of the American College of Cardiology 69, no. 18 (May 9, 2017): 2355–2355.
       Link to Item
    • Bagai, Akshay, Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Marjorie E. Zettler, Gregg W. Stone, Timothy D. Henry, et al. “Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study.” Am Heart J 187 (May 2017): 19–28. https://doi.org/10.1016/j.ahj.2017.02.003.
       Full Text  Link to Item
    • Cowper, Patricia A., Shubin Sheng, Renato D. Lopes, Kevin J. Anstrom, Judith A. Stafford, Linda Davidson-Ray, Sana M. Al-Khatib, et al. “Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial.” Jama Cardiol 2, no. 5 (May 1, 2017): 525–34. https://doi.org/10.1001/jamacardio.2017.0065.
       Full Text  Link to Item
    • Reddy, Yogesh N. V., Gregory D. Lewis, Sanjiv J. Shah, Martin LeWinter, Marc Semigran, Victor G. Davila-Roman, Kevin Anstrom, et al. “INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.” Circ Heart Fail 10, no. 5 (May 2017). https://doi.org/10.1161/CIRCHEARTFAILURE.117.003862.
       Full Text  Link to Item
    • Salisbury, Margaret L., David A. Lynch, Edwin J. R. van Beek, Ella A. Kazerooni, Junfeng Guo, Meng Xia, Susan Murray, et al. “Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.” Am J Respir Crit Care Med 195, no. 7 (April 1, 2017): 921–29. https://doi.org/10.1164/rccm.201607-1385OC.
       Full Text  Link to Item
    • O’Connor, Christopher M., David J. Whellan, Mona Fiuzat, Naresh M. Punjabi, Gudaye Tasissa, Kevin J. Anstrom, Adam V. Benjafield, et al. “Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.” J Am Coll Cardiol 69, no. 12 (March 28, 2017): 1577–87. https://doi.org/10.1016/j.jacc.2017.01.041.
       Full Text  Link to Item
    • Eisenstein, Eric L., Janese M. Willis, Rex Edwards, Kevin J. Anstrom, Kensaku Kawamoto, Guilherme Del Fiol, Fred S. Johnson, and David F. Lobach. “Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions.” Stud Health Technol Inform 234 (2017): 98–103.
       Link to Item
    • Grodin, Justin L., Jie-Lena Sun, Kevin J. Anstrom, Horng H. Chen, Randall C. Starling, Jeffrey M. Testani, and WH Wilson Tang. “Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).” Am J Cardiol 119, no. 1 (January 1, 2017): 78–83. https://doi.org/10.1016/j.amjcard.2016.09.014.
       Full Text  Link to Item
    • Zettler, Marjorie E., Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Kevin J. Anstrom, Timothy D. Henry, Brian A. Baker, et al. “Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study.” Am Heart J 183 (January 2017): 62–68. https://doi.org/10.1016/j.ahj.2016.10.006.
       Full Text  Link to Item
    • Cooper, Lauren B., Xiaojuan Mi, Robert J. Mentz, Jennifer B. Green, Kevin J. Anstrom, Adrian F. Hernandez, and Lesley H. Curtis. “Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.” Clinical Cardiology 40, no. 1 (January 2017): 38–45. https://doi.org/10.1002/clc.22603.
       Full Text
    • Joyce, Emer, Anuradha Lala, Susanna R. Stevens, Lauren B. Cooper, Omar F. AbouEzzeddine, John D. Groarke, Justin L. Grodin, et al. “Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations.” Jacc Heart Fail 4, no. 12 (December 2016): 923–31. https://doi.org/10.1016/j.jchf.2016.09.013.
       Full Text  Link to Item
    • Mehta, Rajendra H., Sean Van Diepen, James Meza, Paula Bokesch, Jeffrey D. Leimberger, Sandra Tourt-Uhlig, Merri Swartz, et al. “Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.” Am Heart J 182 (December 2016): 62–71. https://doi.org/10.1016/j.ahj.2016.09.001.
       Full Text  Link to Item
    • AbouEzzeddine, Omar F., Yee Weng Wong, Robert J. Mentz, Sadi S. Raza, Jose Nativi-Nicolau, Robb D. Kociol, Steven E. McNulty, et al. “Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score.” J Card Fail 22, no. 11 (November 2016): 853–58. https://doi.org/10.1016/j.cardfail.2015.12.015.
       Full Text  Link to Item
    • Brown, Paul M., Kevin J. Anstrom, G Michael Felker, and Justin A. Ezekowitz. “Composite End Points in Acute Heart Failure Research: Data Simulations Illustrate the Limitations.” Can J Cardiol 32, no. 11 (November 2016): 1356.e21-1356.e28. https://doi.org/10.1016/j.cjca.2016.02.067.
       Full Text  Link to Item
    • Fosbøl, Emil L., Christine Ju, Kevin J. Anstrom, Marjorie E. Zettler, John C. Messenger, Ron Waksman, Mark B. Effron, et al. “Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).” Circ Cardiovasc Interv 9, no. 11 (November 2016). https://doi.org/10.1161/CIRCINTERVENTIONS.115.003602.
       Full Text  Link to Item
    • Gandhi, Parul U., Hanna K. Gaggin, Margaret M. Redfield, Horng H. Chen, Susanna R. Stevens, Kevin J. Anstrom, Marc J. Semigran, Peter Liu, and James L. Januzzi. “Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.” Jacc Heart Fail 4, no. 11 (November 2016): 860–69. https://doi.org/10.1016/j.jchf.2016.08.002.
       Full Text  Link to Item
    • Rogers, J. G., C. B. Patel, R. J. Mentz, K. E. Steinhauser, B. B. Granger, M. Fiuzat, P. A. Adams, et al. “Palliative Care in Heart Failure: Results of a Randomized, Controlled Clinical Trial.” Journal of Cardiac Failure 22, no. 11 (November 2016): 940–940. https://doi.org/10.1016/j.cardfail.2016.09.014.
       Full Text
    • Vora, Amit N., Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Kevin J. Anstrom, Douglas E. Faries, Marjorie E. Zettler, et al. “Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.” J Am Heart Assoc 5, no. 9 (September 23, 2016). https://doi.org/10.1161/JAHA.116.003946.
       Full Text  Link to Item
    • Butler, Javed, Adrian F. Hernandez, Kevin J. Anstrom, Andreas Kalogeropoulos, Margaret M. Redfield, Marvin A. Konstam, WH Wilson Tang, G Michael Felker, Monica R. Shah, and Eugene Braunwald. “Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.” Jacc Heart Fail 4, no. 9 (September 2016): 726–35. https://doi.org/10.1016/j.jchf.2016.06.003.
       Full Text  Link to Item
    • Cooper, Lauren B., Robert J. Mentz, Dianne Gallup, Anuradha Lala, Adam D. DeVore, Justin M. Vader, Omar F. AbouEzzeddine, et al. “Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes.” J Card Fail 22, no. 9 (September 2016): 738–42. https://doi.org/10.1016/j.cardfail.2016.01.007.
       Full Text  Link to Item
    • Federspiel, Jerome J., Kevin J. Anstrom, Ying Xian, Lisa A. McCoy, Mark B. Effron, Douglas E. Faries, Marjorie Zettler, et al. “Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention.” Jama Cardiol 1, no. 6 (September 1, 2016): 655–65. https://doi.org/10.1001/jamacardio.2016.1783.
       Full Text  Open Access Copy  Link to Item
    • Raghu, Ganesh, Ellen Morrow, Bridget F. Collins, Lawrence A. T. Ho, Marcelo W. Hinojosa, Jennifer M. Hayes, Carolyn A. Spada, et al. “Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre.” Eur Respir J 48, no. 3 (September 2016): 826–32. https://doi.org/10.1183/13993003.00488-2016.
       Full Text  Link to Item
    • Margulies, Kenneth B., Adrian F. Hernandez, Margaret M. Redfield, Michael M. Givertz, Guilherme H. Oliveira, Robert Cole, Douglas L. Mann, et al. “Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” Jama 316, no. 5 (August 2, 2016): 500–508. https://doi.org/10.1001/jama.2016.10260.
       Full Text  Link to Item
    • Kaul, Padma, E Magnus Ohman, J David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, et al. “Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Am Heart J 178 (August 2016): 55–64. https://doi.org/10.1016/j.ahj.2016.03.017.
       Full Text  Link to Item
    • Kelly, Jacob P., Lauren B. Cooper, Dianne Gallup, Kevin J. Anstrom, Horng H. Chen, Margaret M. Redfield, Christopher M. O’Connor, Robert J. Mentz, Adrian F. Hernanadez, and G Michael Felker. “Implications of Using Different Definitions on Outcomes in Worsening Heart Failure.” Circ Heart Fail 9, no. 8 (August 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.116.003048.
       Full Text  Link to Item
    • Wan, Siu-Hin, Susanna R. Stevens, Barry A. Borlaug, Kevin J. Anstrom, Anita Deswal, G Michael Felker, Michael M. Givertz, et al. “Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).” Circ Heart Fail 9, no. 8 (August 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.115.002593.
       Full Text  Link to Item
    • Mark, Daniel B., Jerome J. Federspiel, Patricia A. Cowper, Kevin J. Anstrom, Udo Hoffmann, Manesh R. Patel, Linda Davidson-Ray, et al. “Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.” Ann Intern Med 165, no. 2 (July 19, 2016): 94–102. https://doi.org/10.7326/M15-2639.
       Full Text  Link to Item
    • Doll, Jacob A., Tracy Y. Wang, Niteesh K. Choudhry, Christopher P. Cannon, David J. Cohen, Gregg C. Fonarow, Timothy D. Henry, et al. “Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.” Am Heart J 177 (July 2016): 33–41. https://doi.org/10.1016/j.ahj.2016.04.008.
       Full Text  Link to Item
    • Zeitler, Emily P., Yongfei Wang, Kumar Dharmarajan, Kevin J. Anstrom, Eric D. Peterson, James P. Daubert, Jeptha P. Curtis, and Sana M. Al-Khatib. “Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.” Circ Arrhythm Electrophysiol 9, no. 7 (July 2016). https://doi.org/10.1161/CIRCEP.116.003953.
       Full Text  Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Shubin Sheng, Khaula N. Baloch, Melanie R. Daniels, Udo Hoffmann, Manesh R. Patel, et al. “Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial.” Circulation 133, no. 21 (May 24, 2016): 1995–2007. https://doi.org/10.1161/CIRCULATIONAHA.115.020259.
       Full Text  Link to Item
    • Lewis, Gregory D., Marc J. Semigran, Michael M. Givertz, Rajeev Malhotra, Kevin J. Anstrom, Adrian F. Hernandez, Monica R. Shah, and Eugene Braunwald. “Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.” Circ Heart Fail 9, no. 5 (May 2016). https://doi.org/10.1161/CIRCHEARTFAILURE.115.000345.
       Full Text  Link to Item
    • Alexander, Karen P., Olena Stadnyuk, Suzanne V. Arnold, Daniel B. Mark, E Magnus Ohman, and Kevin J. Anstrom. “Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey.” Interact J Med Res 5, no. 2 (April 28, 2016): e12. https://doi.org/10.2196/ijmr.4971.
       Full Text  Link to Item
    • Fiuzat, Mona, Olaf Oldenberg, David J. Whellan, Holger Woehrle, Naresh M. Punjabi, Kevin J. Anstrom, Amy B. Blase, Adam V. Benjafield, JoAnn Lindenfeld, and Christopher M. O’Connor. “Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study.” Contemp Clin Trials 47 (March 2016): 158–64. https://doi.org/10.1016/j.cct.2016.01.001.
       Full Text  Link to Item
    • Partin, Melissa R., Aasma Shaukat, David B. Nelson, Amy Gravely, Sean Nugent, Ziad F. Gellad, and James F. Burgess. “Reply.” Clin Gastroenterol Hepatol 14, no. 3 (March 2016): 486. https://doi.org/10.1016/j.cgh.2015.12.008.
       Full Text  Link to Item
    • AbouEzzeddine, Omar F., Anuradha Lala, Prateeti P. Khazanie, Ravi Shah, Jennifer E. Ho, Horng H. Chen, Peter S. Pang, et al. “Evaluation of a provocative dyspnea severity score in acute heart failure.” Am Heart J 172 (February 2016): 34–41. https://doi.org/10.1016/j.ahj.2015.10.009.
       Full Text  Link to Item
    • Mentz, Robert J., Vic Hasselblad, Adam D. DeVore, Marco Metra, Adriaan A. Voors, Paul W. Armstrong, Justin A. Ezekowitz, et al. “Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).” Am J Cardiol 117, no. 3 (February 1, 2016): 404–11. https://doi.org/10.1016/j.amjcard.2015.10.059.
       Full Text  Link to Item
    • Krishnamoorthy, Arun, Eric D. Peterson, J David Knight, Kevin J. Anstrom, Mark B. Effron, Marjorie E. Zettler, Linda Davidson-Ray, et al. “How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies.” J Am Heart Assoc 5, no. 1 (January 25, 2016). https://doi.org/10.1161/JAHA.115.002695.
       Full Text  Open Access Copy  Link to Item
    • Alexander, Karen P., Giora Weisz, Kristi Prather, Stefan James, Daniel B. Mark, Kevin J. Anstrom, Linda Davidson-Ray, et al. “Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.” Circulation 133, no. 1 (January 5, 2016): 39–47. https://doi.org/10.1161/CIRCULATIONAHA.115.019768.
       Full Text  Link to Item
    • Brennan, J Matthew, Michael H. Sketch, David Dai, Marina Trilesskaya, Wesam Al-Hejily, Sunil V. Rao, Emmanouil Brilakis, et al. “Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).” Catheter Cardiovasc Interv 87, no. 1 (January 1, 2016): 43–49. https://doi.org/10.1002/ccd.25979.
       Full Text  Link to Item
    • Grodin, Justin L., Susanna R. Stevens, Lisa de Las Fuentes, Michael Kiernan, Edo Y. Birati, Divya Gupta, Bradley A. Bart, et al. “Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.” J Card Fail 22, no. 1 (January 2016): 26–32. https://doi.org/10.1016/j.cardfail.2015.07.007.
       Full Text  Link to Item
    • Kawamoto, Kensaku, Kevin J. Anstrom, John B. Anderson, Hayden B. Bosworth, David F. Lobach, Carrie McAdam-Marx, Jeffrey M. Ferranti, Howard Shang, and Kimberly S. H. Yarnall. “Long-Term Impact of an Electronic Health Record-Enabled, Team-Based, and Scalable Population Health Strategy Based on the Chronic Care Model.” Amia Annu Symp Proc 2016 (2016): 686–95.
       Link to Item
    • O’Brien, Emily C., Michael T. Durheim, Victoria Gamerman, Sandy Garfinkel, Kevin J. Anstrom, Scott M. Palmer, and Craig S. Conoscenti. “Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.” Bmj Open Respir Res 3, no. 1 (2016): e000108. https://doi.org/10.1136/bmjresp-2015-000108.
       Full Text  Link to Item
    • Oldham, Justin M., Shwu-Fan Ma, Fernando J. Martinez, Kevin J. Anstrom, Ganesh Raghu, David A. Schwartz, Eleanor Valenzi, et al. “TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.” Am J Respir Crit Care Med 192, no. 12 (December 15, 2015): 1475–82. https://doi.org/10.1164/rccm.201505-1010OC.
       Full Text  Link to Item
    • Redfield, Margaret M., Kevin J. Anstrom, James A. Levine, Gabe A. Koepp, Barry A. Borlaug, Horng H. Chen, Martin M. LeWinter, et al. “Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.” N Engl J Med 373, no. 24 (December 10, 2015): 2314–24. https://doi.org/10.1056/NEJMoa1510774.
       Full Text  Link to Item
    • Bagai, Akshay, Eric D. Peterson, Emily Honeycutt, Mark B. Effron, David J. Cohen, Shaun G. Goodman, Kevin J. Anstrom, Anjan Gupta, John C. Messenger, and Tracy Y. Wang. “In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.” Eur Heart J Acute Cardiovasc Care 4, no. 6 (December 2015): 499–508. https://doi.org/10.1177/2048872614564082.
       Full Text  Link to Item
    • Andrade, Joao de, Marvin Schwarz, Harold R. Collard, Tedryl Gentry-Bumpass, Thomas Colby, David Lynch, Robert J. Kaner, and Robert J. IPFnet Investigators. “The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.” Chest 148, no. 4 (October 2015): 1034–42. https://doi.org/10.1378/chest.14-2889.
       Full Text  Link to Item
    • Mentz, Robert J., Eric J. Velazquez, Marco Metra, Colleen McKendry, Karen Chiswell, Mona Fiuzat, Michael M. Givertz, Adriaan A. Voors, John R. Teerlink, and Christopher M. O’Connor. “Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.” Future Cardiol 11, no. 5 (September 2015): 585–95. https://doi.org/10.2217/fca.15.56.
       Full Text  Link to Item
    • Khazanie, Prateeti, Anne S. Hellkamp, Gregg C. Fonarow, Deepak L. Bhatt, Frederick A. Masoudi, Kevin J. Anstrom, Paul A. Heidenreich, et al. “Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.” J Am Heart Assoc 4, no. 8 (August 6, 2015): e002061. https://doi.org/10.1161/JAHA.115.002061.
       Full Text  Open Access Copy  Link to Item
    • Hess, Connie N., Mitchell W. Krucoff, Shubin Sheng, Kevin J. Anstrom, W Britt Barham, Ian C. Gilchrist, Robert A. Harrington, et al. “Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy.” Am Heart J 170, no. 2 (August 2015): 371–79. https://doi.org/10.1016/j.ahj.2015.04.024.
       Full Text  Link to Item
    • Lala, Anuradha, Steven E. McNulty, Robert J. Mentz, Shannon M. Dunlay, Justin M. Vader, Omar F. AbouEzzeddine, Adam D. DeVore, et al. “Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).” Circ Heart Fail 8, no. 4 (July 2015): 741–48. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001957.
       Full Text  Open Access Copy  Link to Item
    • Wang, Tracy Y., Timothy D. Henry, Mark B. Effron, Emily Honeycutt, Connie N. Hess, Marjorie E. Zettler, David J. Cohen, et al. “Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study.” Circ Cardiovasc Interv 8, no. 6 (June 2015): e001712. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001712.
       Full Text  Link to Item
    • Givertz, Michael M., Kevin J. Anstrom, Margaret M. Redfield, Anita Deswal, Haissam Haddad, Javed Butler, WH Wilson Tang, et al. “Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.” Circulation 131, no. 20 (May 19, 2015): 1763–71. https://doi.org/10.1161/CIRCULATIONAHA.114.014536.
       Full Text  Link to Item
    • Steinberg, Benjamin Adam, Phillip Joel Schulte, Paul Hofmann, Mads Ersbøll, John Hunter Alexander, Kathleen Broderick-Forsgren, Kevin Joseph Anstrom, et al. “Outcomes after nonemergent electrical cardioversion for atrial arrhythmias.” Am J Cardiol 115, no. 10 (May 15, 2015): 1407–14. https://doi.org/10.1016/j.amjcard.2015.02.030.
       Full Text  Link to Item
    • Durheim, Michael T., Harold R. Collard, Rhonda S. Roberts, Kevin K. Brown, Kevin R. Flaherty, Talmadge E. King, Scott M. Palmer, et al. “Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.” Lancet Respir Med 3, no. 5 (May 2015): 388–96. https://doi.org/10.1016/S2213-2600(15)00093-4.
       Full Text  Link to Item
    • Mentz, Robert J., Jonathan Buggey, Mona Fiuzat, Mads K. Ersbøll, Phillip J. Schulte, Adam D. DeVore, Eric L. Eisenstein, Kevin J. Anstrom, Christopher M. OʼConnor, and Eric J. Velazquez. “Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.” J Cardiovasc Pharmacol 65, no. 5 (May 2015): 438–43. https://doi.org/10.1097/FJC.0000000000000212.
       Full Text  Open Access Copy  Link to Item
    • Arnold, Christopher J., Melissa Johnson, Arnold S. Bayer, Suzanne Bradley, Efthymia Giannitsioti, José M. Miró, Pilar Tornos, et al. “Candida infective endocarditis: an observational cohort study with a focus on therapy.” Antimicrob Agents Chemother 59, no. 4 (April 2015): 2365–73. https://doi.org/10.1128/AAC.04867-14.
       Full Text  Link to Item
    • Brennan, J Matthew, Wesam Al-Hejily, David Dai, Richard E. Shaw, Marina Trilesskaya, Sunil V. Rao, Emmanouil S. Brilakis, et al. “Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry.” Circ Cardiovasc Interv 8, no. 3 (March 2015): e001403. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001403.
       Full Text  Link to Item
    • Buggey, Jonathan, Robert J. Mentz, Bertram Pitt, Eric L. Eisenstein, Kevin J. Anstrom, Eric J. Velazquez, and Christopher M. O’Connor. “A reappraisal of loop diuretic choice in heart failure patients.” Am Heart J 169, no. 3 (March 2015): 323–33. https://doi.org/10.1016/j.ahj.2014.12.009.
       Full Text  Link to Item
    • Chirouze, Catherine, François Alla, Vance G. Fowler, Daniel J. Sexton, G Ralph Corey, Vivian H. Chu, Andrew Wang, et al. “Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.” Clin Infect Dis 60, no. 5 (March 1, 2015): 741–49. https://doi.org/10.1093/cid/ciu871.
       Full Text  Link to Item
    • Cowper, Patricia A., Wenqin Pan, Kevin J. Anstrom, Padma Kaul, Lars Wallentin, Linda Davidson-Ray, Elisabet Nikolic, et al. “Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.” J Am Coll Cardiol 65, no. 5 (February 10, 2015): 465–76. https://doi.org/10.1016/j.jacc.2014.11.034.
       Full Text  Link to Item
    • Al-Khatib, Sana M., James P. Daubert, Kevin J. Anstrom, Emile G. Daoud, Mario Gonzalez, Samir Saba, Kevin P. Jackson, et al. “Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.” J Cardiovasc Electrophysiol 26, no. 2 (February 2015): 151–57. https://doi.org/10.1111/jce.12567.
       Full Text  Link to Item
    • Mentz, Robert J., Susanna R. Stevens, Adam D. DeVore, Anuradha Lala, Justin M. Vader, Omar F. AbouEzzeddine, Prateeti Khazanie, et al. “Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.” Jacc Heart Fail 3, no. 2 (February 2015): 97–107. https://doi.org/10.1016/j.jchf.2014.09.003.
       Full Text  Open Access Copy  Link to Item
    • Pokorney, Sean D., Anne S. Hellkamp, Clyde W. Yancy, Lesley H. Curtis, Stephen C. Hammill, Eric D. Peterson, Frederick A. Masoudi, et al. “Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.” Circ Arrhythm Electrophysiol 8, no. 1 (February 2015): 145–51. https://doi.org/10.1161/CIRCEP.114.001878.
       Full Text  Link to Item
    • Povsic, Thomas J., Samuel Broderick, Kevin J. Anstrom, Linda K. Shaw, E Magnus Ohman, Eric L. Eisenstein, Peter K. Smith, and John H. Alexander. “Predictors of Long-term Clinical Endpoints in Patients With Refractory Angina.” Journal of the American Heart Association 4, no. 2 (February 2015). https://doi.org/10.1161/JAHA.114.001287.
       Full Text  Link to Item
    • Zeitler, Emily P., Anne S. Hellkamp, Gregg C. Fonarow, Stephen C. Hammill, Lesley H. Curtis, Adrian F. Hernandez, Hussein R. Al-Khalidi, et al. “Primary prevention implantable cardioverter-defibrillators and survival in older women.” Jacc Heart Fail 3, no. 2 (February 2015): 159–67. https://doi.org/10.1016/j.jchf.2014.09.006.
       Full Text  Link to Item
    • Povsic, Thomas J., Samuel Broderick, Kevin J. Anstrom, Linda K. Shaw, E Magnus Ohman, Eric L. Eisenstein, Peter K. Smith, and John H. Alexander. “Predictors of long-term clinical endpoints in patients with refractory angina.” J Am Heart Assoc 4, no. 2 (January 30, 2015). https://doi.org/10.1161/JAHA.114.001287.
       Full Text  Link to Item
    • Delahaye, F., V. H. Chu, J. Altclas, B. Barsic, A. Delahaye, T. Freiberger, D. L. Gordon, et al. “One-year outcome following biological or mechanical valve replacement for infective endocarditis.” Int J Cardiol 178 (January 15, 2015): 117–23. https://doi.org/10.1016/j.ijcard.2014.10.125.
       Full Text  Link to Item
    • Chu, Vivian H., Lawrence P. Park, Eugene Athan, Francois Delahaye, Tomas Freiberger, Cristiane Lamas, Jose M. Miro, et al. “Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.” Circulation 131, no. 2 (January 13, 2015): 131–40. https://doi.org/10.1161/CIRCULATIONAHA.114.012461.
       Full Text  Link to Item
    • Zakeri, Rosita, James A. Levine, Gabriel A. Koepp, Barry A. Borlaug, Julio A. Chirinos, Martin LeWinter, Peter VanBuren, et al. “Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design.” Circ Heart Fail 8, no. 1 (January 2015): 221–28. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001598.
       Full Text  Link to Item
    • Steinberg, Benjamin A., Philip Schulte, Paul Hofmann, Mads Ersboll, John H. Alexander, Kathleen Broderick-Forsgren, Kevin J. Anstrom, et al. “Contemporary Use and Clinical Outcomes Following Non-Emergent Electrical Cardioversion for Atrial Fibrillation.” Circulation 130 (November 25, 2014).
       Link to Item
    • Collard, Harold R., Kevin K. Brown, Fernando J. Martinez, Ganesh Raghu, Rhonda S. Roberts, and Kevin J. Anstrom. “Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis.” Chest 146, no. 5 (November 2014): 1256–62. https://doi.org/10.1378/chest.14-0492.
       Full Text  Link to Item
    • Mentz, Robert J., James A. Tulsky, Bradi B. Granger, Kevin J. Anstrom, Patricia A. Adams, Gwen C. Dodson, Mona Fiuzat, et al. “The palliative care in heart failure trial: rationale and design.” Am Heart J 168, no. 5 (November 2014): 645-651.e1. https://doi.org/10.1016/j.ahj.2014.07.018.
       Full Text  Link to Item
    • Xian, Ying, Robert G. Holloway, Eric E. Smith, Lee H. Schwamm, Mathew J. Reeves, Deepak L. Bhatt, Phillip J. Schulte, et al. “Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage.” Stroke 45, no. 11 (November 2014): 3243–50. https://doi.org/10.1161/STROKEAHA.114.005620.
       Full Text  Link to Item
    • Felker, G Michael, Tariq Ahmad, Kevin J. Anstrom, Kirkwood F. Adams, Lawton S. Cooper, Justin A. Ezekowitz, Mona Fiuzat, et al. “Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.” Jacc Heart Fail 2, no. 5 (October 2014): 457–65. https://doi.org/10.1016/j.jchf.2014.05.007.
       Full Text  Link to Item
    • Grotegut, C. A., E. V. Kuklina, K. J. Anstrom, R. P. Heine, W. M. Callaghan, E. R. Myers, and A. H. James. “Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: a population-based prevalence study.” Bjog 121, no. 11 (October 2014): 1386–94. https://doi.org/10.1111/1471-0528.12726.
       Full Text  Link to Item
    • Hess, Paul L., Anne S. Hellkamp, Eric D. Peterson, Gillian D. Sanders, Hussein R. Al-Khalidi, Lesley H. Curtis, Bradley G. Hammill, et al. “Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.” Circ Arrhythm Electrophysiol 7, no. 5 (October 2014): 793–99. https://doi.org/10.1161/CIRCEP.114.001455.
       Full Text  Link to Item
    • Mark, Daniel B., J David Knight, Eric J. Velazquez, Jaroslaw Wasilewski, Jonathan G. Howlett, Peter K. Smith, John A. Spertus, et al. “Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial.” Ann Intern Med 161, no. 6 (September 16, 2014): 392–99. https://doi.org/10.7326/M13-1380.
       Full Text  Link to Item
    • Anstrom, Kevin J., J Matthew Brennan, Eric L. Eisenstein, Jerome J. Federspiel, David Dai, Eric D. Peterson, and Pamela S. Douglas. “Examination of the treatment selection process in a multicenter observational study.” Circ Cardiovasc Qual Outcomes 7, no. 5 (September 2014): 764–69. https://doi.org/10.1161/CIRCOUTCOMES.113.000482.
       Full Text  Link to Item
    • Piccini, Jonathan P., Sana M. Al-Khatib, Daniel M. Wojdyla, Linda K. Shaw, John R. Horton, Yuliya Lokhnygina, Kevin J. Anstrom, et al. “Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.” Am J Cardiol 114, no. 5 (September 1, 2014): 716–22. https://doi.org/10.1016/j.amjcard.2014.06.004.
       Full Text  Link to Item
    • Hess, Connie N., Matthew T. Roe, C Michael Gibson, Robert J. Temple, Michael J. Pencina, Deborah A. Zarin, Kevin J. Anstrom, et al. “Independent data monitoring committees: preparing a path for the future.” Am Heart J 168, no. 2 (August 2014): 135-41.e1. https://doi.org/10.1016/j.ahj.2014.05.003.
       Full Text  Link to Item
    • Rao, Sunil V., Connie N. Hess, Britt Barham, Laura H. Aberle, Kevin J. Anstrom, Tejan B. Patel, Jesse P. Jorgensen, et al. “A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.” Jacc Cardiovasc Interv 7, no. 8 (August 2014): 857–67. https://doi.org/10.1016/j.jcin.2014.04.007.
       Full Text  Link to Item
    • Margulies, Kenneth B., Kevin J. Anstrom, Adrian F. Hernandez, Margaret M. Redfield, Monica R. Shah, Eugene Braunwald, Thomas P. Cappola, and Thomas P. Heart Failure Clinical Research Network. “GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.” Circ Heart Fail 7, no. 4 (July 2014): 673–79. https://doi.org/10.1161/CIRCHEARTFAILURE.114.000346.
       Full Text  Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Nancy E. Clapp-Channing, J David Knight, Robin Boineau, Christine Goertz, Theodore C. Rozema, et al. “Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial.” Circ Cardiovasc Qual Outcomes 7, no. 4 (July 2014): 508–16. https://doi.org/10.1161/CIRCOUTCOMES.114.000977.
       Full Text  Link to Item
    • “Comparative effectiveness of drug‐eluting stents on long‐term outcomes in elderly patients treated for in‐stent restenosis: A report from the National Cardiovascular Data Registry.” Catheterization and Cardiovascular Interventions 84, no. 1 (July 2014): 168–168. https://doi.org/10.1002/ccd.25501.
       Full Text
    • Al-Khatib, Sana M., Anne S. Hellkamp, Gregg C. Fonarow, Daniel B. Mark, Lesley H. Curtis, Adrian F. Hernandez, Kevin J. Anstrom, et al. “Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.” Jama 311, no. 21 (June 4, 2014): 2209–15. https://doi.org/10.1001/jama.2014.5310.
       Full Text  Link to Item
    • Douglas, Pamela S., Udo Hoffmann, Kerry L. Lee, Daniel B. Mark, Hussein R. Al-Khalidi, Kevin Anstrom, Rowena J. Dolor, et al. “PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial.” Am Heart J 167, no. 6 (June 2014): 796-803.e1. https://doi.org/10.1016/j.ahj.2014.03.003.
       Full Text  Link to Item
    • Idiopathic Pulmonary Fibrosis Clinical Research Network, Ganesh, Fernando J. Martinez, Joao A. de Andrade, Kevin J. Anstrom, Talmadge E. King, and Ganesh Raghu. “Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.” N Engl J Med 370, no. 22 (May 29, 2014): 2093–2101. https://doi.org/10.1056/NEJMoa1401739.
       Full Text  Link to Item
    • Miller, Timothy E., Julie K. Thacker, William D. White, Christopher Mantyh, John Migaly, Juying Jin, Anthony M. Roche, et al. “Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol.” Anesth Analg 118, no. 5 (May 2014): 1052–61. https://doi.org/10.1213/ANE.0000000000000206.
       Full Text  Open Access Copy  Link to Item
    • Kutcher, Michael A., J Matthew Brennan, Sunil V. Rao, David Dai, Kevin J. Anstrom, Nowwar Mustafa, Art Sedrakyan, Michael E. Booth, Pamela S. Douglas, and John C. Messenger. “Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.” Catheter Cardiovasc Interv 83, no. 2 (February 2014): 171–81. https://doi.org/10.1002/ccd.25108.
       Full Text  Link to Item
    • Blackwell, Timothy S., Andrew M. Tager, Zea Borok, Bethany B. Moore, David A. Schwartz, Kevin J. Anstrom, Ziv Bar-Joseph, et al. “Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.” Am J Respir Crit Care Med 189, no. 2 (January 15, 2014): 214–22. https://doi.org/10.1164/rccm.201306-1141WS.
       Full Text  Link to Item
    • Moore, B. B., C. Fry, Y. Zhou, S. Murray, M. L. K. Han, F. J. Martinez, K. R. Flaherty, et al. “Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.” Frontiers in Medicine 1, no. DEC (January 1, 2014). https://doi.org/10.3389/fmed.2014.00056.
       Full Text
    • Swigris, Jeffrey J., David L. Streiner, Kevin K. Brown, Amanda Belkin, Kathy E. Green, Frederick S. Wamboldt, and Frederick S. IPFnet Investigators. “Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.” Respir Med 108, no. 1 (January 2014): 181–88. https://doi.org/10.1016/j.rmed.2013.12.009.
       Full Text  Link to Item
    • Chen, Horng H., Kevin J. Anstrom, Michael M. Givertz, Lynne W. Stevenson, Marc J. Semigran, Steven R. Goldsmith, Bradley A. Bart, et al. “Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.” Jama 310, no. 23 (December 18, 2013): 2533–43. https://doi.org/10.1001/jama.2013.282190.
       Full Text  Link to Item
    • Chen, Horng H., Barry A. Borlaug, Kevin J. Anstrom, G. M. Felker, Michael M. Givertz, Anita Deswal, Bradley A. Bart, et al. “Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial.” Circulation 128, no. 24 (December 17, 2013): 2707–8.
       Link to Item
    • Chen, Horng H., Omar F. AbouEzzeddine, Kevin J. Anstrom, Michael M. Givertz, Bradley A. Bart, G Michael Felker, Adrian F. Hernandez, et al. “Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.” Circ Heart Fail 6, no. 5 (September 1, 2013): 1087–94. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000347.
       Full Text  Link to Item
    • Hess, Connie N., Sunil V. Rao, David F. Kong, Laura H. Aberle, Kevin J. Anstrom, C Michael Gibson, Ian C. Gilchrist, et al. “Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).” Am Heart J 166, no. 3 (September 2013): 421–28. https://doi.org/10.1016/j.ahj.2013.06.013.
       Full Text  Link to Item
    • Eisenstein, Eric L., Linda Davidson-Ray, Rex Edwards, Kevin J. Anstrom, and Kenneth Ouriel. “Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms.” J Vasc Surg 58, no. 2 (August 2013): 302–10. https://doi.org/10.1016/j.jvs.2013.01.038.
       Full Text  Link to Item
    • Collard, Harold R., Eric Yow, Luca Richeldi, Kevin J. Anstrom, Craig Glazer, and Craig IPFnet investigators. “Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.” Respir Res 14 (July 13, 2013): 73. https://doi.org/10.1186/1465-9921-14-73.
       Full Text  Link to Item
    • Lee, Joyce S., Harold R. Collard, Kevin J. Anstrom, Fernando J. Martinez, Imre Noth, Rhonda S. Roberts, Eric Yow, Ganesh Raghu, and Ganesh IPFnet Investigators. “Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.” Lancet Respir Med 1, no. 5 (July 2013): 369–76. https://doi.org/10.1016/S2213-2600(13)70105-X.
       Full Text  Link to Item
    • Han, MeiLan K., David S. Bach, Peter G. Hagan, Eric Yow, Kevin R. Flaherty, Galen B. Toews, Kevin J. Anstrom, Fernando J. Martinez, and Fernando J. IPFnet Investigators. “Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.” Chest 143, no. 6 (June 2013): 1699–1708. https://doi.org/10.1378/chest.12-1594.
       Full Text  Link to Item
    • Raghu, Ganesh, Harold R. Collard, Kevin J. Anstrom, Kevin R. Flaherty, Thomas R. Fleming, Talmadge E. King, Fernando J. Martinez, and Kevin K. Brown. “Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.” Am J Respir Crit Care Med 187, no. 11 (June 1, 2013): 1272. https://doi.org/10.1164/rccm.201304-0712LE.
       Full Text  Link to Item
    • Kumar, Robert S., Pamela S. Douglas, Eric D. Peterson, Kevin J. Anstrom, David Dai, J Matthew Brennan, Peter Y. M. Hui, Michael E. Booth, John C. Messenger, and Richard E. Shaw. “Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.” Circulation 127, no. 13 (April 2, 2013): 1395–1403. https://doi.org/10.1161/CIRCULATIONAHA.113.001437.
       Full Text  Link to Item
    • Redfield, Margaret M., Horng H. Chen, Barry A. Borlaug, Marc J. Semigran, Kerry L. Lee, Gregory Lewis, Martin M. LeWinter, et al. “Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.” Jama 309, no. 12 (March 27, 2013): 1268–77. https://doi.org/10.1001/jama.2013.2024.
       Full Text  Link to Item
    • Hess, Connie N., Sunil V. Rao, David F. Kong, Julie M. Miller, Kevin J. Anstrom, Olivier F. Bertrand, Jean-Philippe Collet, et al. “TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.” Am Heart J 165, no. 3 (March 2013): 344-53.e1. https://doi.org/10.1016/j.ahj.2012.09.008.
       Full Text  Link to Item
    • Dewitt, Esi Morgan, Yanhong Li, Jeffrey R. Curtis, Henry A. Glick, Jeffrey D. Greenberg, Kevin J. Anstrom, Joel M. Kremer, George Reed, Kevin A. Schulman, and Shelby D. Reed. “Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.” J Rheumatol 40, no. 2 (February 2013): 127–36. https://doi.org/10.3899/jrheum.120400.
       Full Text  Link to Item
    • Lobach, David F., Kensaku Kawamoto, Kevin J. Anstrom, Garry M. Silvey, Janese M. Willis, Fred S. Johnson, Rex Edwards, et al. “A randomized trial of population-based clinical decision support to manage health and resource use for Medicaid beneficiaries.” J Med Syst 37, no. 1 (February 2013): 9922. https://doi.org/10.1007/s10916-012-9922-3.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Anne Hellkamp, Gust H. Bardy, Stephen Hammill, W Jackson Hall, Daniel B. Mark, Kevin J. Anstrom, et al. “Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.” Jama 309, no. 1 (January 2, 2013): 55–62. https://doi.org/10.1001/jama.2012.157182.
       Full Text  Link to Item
    • Chambers, Stephen T., David Murdoch, Arthur Morris, David Holland, Paul Pappas, Manel Almela, Nuria Fernández-Hidalgo, et al. “HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.” Plos One 8, no. 5 (2013): e63181. https://doi.org/10.1371/journal.pone.0063181.
       Full Text  Link to Item
    • Willis, Janese M., Rex Edwards, Kevin J. Anstrom, Fred S. Johnson, Guilherme Del Fiol, Kensaku Kawamoto, Nancy M Allen Lapointe, Eric L. Eisenstein, and David F. Lobach. “Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use.” Stud Health Technol Inform 183 (2013): 116–25.
       Link to Item
    • Bart, Bradley A., Steven R. Goldsmith, Kerry L. Lee, Michael M. Givertz, Christopher M. O’Connor, David A. Bull, Margaret M. Redfield, et al. “Ultrafiltration in decompensated heart failure with cardiorenal syndrome.” N Engl J Med 367, no. 24 (December 13, 2012): 2296–2304. https://doi.org/10.1056/NEJMoa1210357.
       Full Text  Link to Item
    • Hillegass, William B., Manesh R. Patel, Lloyd W. Klein, Hitinder S. Gurm, J Matthew Brennan, Kevin J. Anstrom, David Dai, et al. “Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.” J Am Coll Cardiol 60, no. 22 (December 4, 2012): 2280–89. https://doi.org/10.1016/j.jacc.2012.08.993.
       Full Text  Link to Item
    • Eisenstein, Eric L., Daniel Wojdyla, Kevin J. Anstrom, J Matthew Brennan, Robert M. Califf, Eric D. Peterson, and Pamela S. Douglas. “Evaluating the impact of public health notification: Duke clopidogrel experience.” Circ Cardiovasc Qual Outcomes 5, no. 6 (November 2012): 767–74. https://doi.org/10.1161/CIRCOUTCOMES.111.963330.
       Full Text  Link to Item
    • Gupta, Achal, Eugene Braunwald, Steven McNulty, G Michael Felker, E Michael Gilbert, Rami Alharethi, Kerry L. Lee, et al. “Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy.” J Card Fail 18, no. 11 (November 2012): 837–44. https://doi.org/10.1016/j.cardfail.2012.09.005.
       Full Text  Link to Item
    • Anderson, Monique L., Eric D. Peterson, J Matthew Brennan, Sunil V. Rao, David Dai, Kevin J. Anstrom, Robert Piana, et al. “Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort.” Circulation 126, no. 18 (October 30, 2012): 2190–99. https://doi.org/10.1161/CIRCULATIONAHA.112.111369.
       Full Text  Link to Item
    • Patel, Manesh R., Steven P. Marso, David Dai, Kevin J. Anstrom, Kendrick A. Shunk, Jeptha P. Curtus, J Matthew Brennan, Art Sedrakyan, John C. Messenger, and Pamela S. Douglas. “Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.” Jacc Cardiovasc Interv 5, no. 10 (October 2012): 1054–61. https://doi.org/10.1016/j.jcin.2012.05.017.
       Full Text  Link to Item
    • Swigris, Jeffrey J., Meilan Han, Rekha Vij, Imre Noth, Eric L. Eisenstein, Kevin J. Anstrom, Kevin K. Brown, and Diane Fairclough. “The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.” Respir Med 106, no. 10 (October 2012): 1447–55. https://doi.org/10.1016/j.rmed.2012.06.018.
       Full Text  Link to Item
    • Subherwal, Sumeet, Kevin J. Anstrom, William S. Jones, Michael G. Felker, Sanjay Misra, Michael S. Conte, William R. Hiatt, and Manesh R. Patel. “Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.” Am Heart J 164, no. 3 (September 2012): 277–84. https://doi.org/10.1016/j.ahj.2012.07.002.
       Full Text  Link to Item
    • Noth, Imre, Kevin J. Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R. Flaherty, Craig Glazer, Robert J. Kaner, Mitchell A. Olman, and Mitchell A. Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet). “A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.” Am J Respir Crit Care Med 186, no. 1 (July 1, 2012): 88–95. https://doi.org/10.1164/rccm.201202-0314OC.
       Full Text  Link to Item
    • Idiopathic Pulmonary Fibrosis Clinical Research Network, Fernando J., Ganesh Raghu, Kevin J. Anstrom, Talmadge E. King, Joseph A. Lasky, and Fernando J. Martinez. “Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.” N Engl J Med 366, no. 21 (May 24, 2012): 1968–77. https://doi.org/10.1056/NEJMoa1113354.
       Full Text  Link to Item
    • Raghu, Ganesh, Harold R. Collard, Kevin J. Anstrom, Kevin R. Flaherty, Thomas R. Fleming, Talmadge E. King, Fernando J. Martinez, and Kevin K. Brown. “Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.” Am J Respir Crit Care Med 185, no. 10 (May 15, 2012): 1044–48. https://doi.org/10.1164/rccm.201201-0006PP.
       Full Text  Link to Item
    • Calvert, Sara Bristol, Judith M. Kramer, Kevin J. Anstrom, Lisa A. Kaltenbach, Judith A. Stafford, and Nancy M. Allen LaPointe. “Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.” Am Heart J 163, no. 4 (April 2012): 657-65.e1. https://doi.org/10.1016/j.ahj.2012.01.019.
       Full Text  Link to Item
    • Brennan, J Matthew, David Dai, Manesh R. Patel, Sunil V. Rao, Ehrin J. Armstrong, John C. Messenger, Jeptha P. Curtis, et al. “Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.” J Am Coll Cardiol 59, no. 7 (February 14, 2012): 648–54. https://doi.org/10.1016/j.jacc.2011.10.883.
       Full Text  Link to Item
    • Wang, Tracy Y., Frederick A. Masoudi, John C. Messenger, Kendrick A. Shunk, Andrew Boyle, J Matthew Brennan, H Vernon Anderson, et al. “Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States.” J Am Coll Cardiol 59, no. 2 (January 10, 2012): 105–12. https://doi.org/10.1016/j.jacc.2011.10.853.
       Full Text  Link to Item
    • Brennan, J Matthew, Eric D. Peterson, John C. Messenger, John S. Rumsfeld, William S. Weintraub, Kevin J. Anstrom, Eric L. Eisenstein, et al. “Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization.” Circ Cardiovasc Qual Outcomes 5, no. 1 (January 2012): 134–40. https://doi.org/10.1161/CIRCOUTCOMES.111.963280.
       Full Text  Link to Item
    • Eisenstein, Eric L., David F. Kong, Patricia A. Cowper, Jay P. Bae, Krishnan Ramaswamy, and Kevin J. Anstrom. “Nonfatal myocardial infarction and long-term outcomes in coronary artery disease.” Am Heart J 163, no. 1 (January 2012): 95–103. https://doi.org/10.1016/j.ahj.2011.09.024.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kevin J. Anstrom, Rex Edwards, Janese M. Willis, Jessica Simo, and David F. Lobach. “Population-based clinical decision support: a clinical and economic evaluation.” Stud Health Technol Inform 180 (2012): 343–47.
       Link to Item
    • Chin, Chee Tang, Tracy Y. Wang, Kevin J. Anstrom, Baojin Zhu, Jen-Fue Maa, John C. Messenger, Kelley A. Ryan, et al. “Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research.” Am Heart J 162, no. 5 (November 2011): 844–51. https://doi.org/10.1016/j.ahj.2011.08.021.
       Full Text  Link to Item
    • Tsai, Thomas T., John C. Messenger, J Matthew Brennan, Uptal D. Patel, David Dai, Robert N. Piana, Kevin J. Anstrom, et al. “Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.” J Am Coll Cardiol 58, no. 18 (October 25, 2011): 1859–69. https://doi.org/10.1016/j.jacc.2011.06.056.
       Full Text  Link to Item
    • Mark, Daniel B., Manesh R. Patel, and Kevin J. Anstrom. “Trade-offs and toss-ups: making revascularization decisions in carotid artery disease.” J Am Coll Cardiol 58, no. 15 (October 4, 2011): 1566–68. https://doi.org/10.1016/j.jacc.2011.07.012.
       Full Text  Link to Item
    • Glickman, Seth W., Samantha Phillips, Kevin J. Anstrom, Daniel T. Laskowitz, and Charles B. Cairns. “Discriminative capacity of biomarkers for acute stroke in the emergency department.” J Emerg Med 41, no. 3 (September 2011): 333–39. https://doi.org/10.1016/j.jemermed.2010.02.025.
       Full Text  Link to Item
    • Anstrom, Kevin J., and Eric L. Eisenstein. “From batting average to wins above replacement to composite end points-refining clinical research using baseball statistical methods.” Am Heart J 161, no. 5 (May 2011): 805–6. https://doi.org/10.1016/j.ahj.2011.01.023.
       Full Text  Link to Item
    • Felker, G Michael, Kerry L. Lee, David A. Bull, Margaret M. Redfield, Lynne W. Stevenson, Steven R. Goldsmith, Martin M. LeWinter, et al. “Diuretic strategies in patients with acute decompensated heart failure.” N Engl J Med 364, no. 9 (March 3, 2011): 797–805. https://doi.org/10.1056/NEJMoa1005419.
       Full Text  Link to Item
    • Piccini, Jonathan P., Sana M. Al-Khatib, Anne S. Hellkamp, Kevin J. Anstrom, Jeanne E. Poole, Daniel B. Mark, Kerry L. Lee, and Gust H. Bardy. “Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).” Heart Rhythm 8, no. 3 (March 2011): 393–400. https://doi.org/10.1016/j.hrthm.2010.11.033.
       Full Text  Link to Item
    • Olsen, Elise A., Valerie Callender, Amy McMichael, Leonard Sperling, Kevin J. Anstrom, Jerry Shapiro, Janet Roberts, Faith Durden, David Whiting, and Wilma Bergfeld. “Central hair loss in African American women: incidence and potential risk factors.” J Am Acad Dermatol 64, no. 2 (February 2011): 245–52. https://doi.org/10.1016/j.jaad.2009.11.693.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kensaku Kawamoto, Kevin J. Anstrom, Janese M. Willis, Garry M. Silvey, Fred S. Johnson, Rex Edwards, Jean Mise, Susan D. Yaggy, and David F. Lobach. “Clinical and economic results from a randomized trial of clinical decision support in a rural health network.” Stud Health Technol Inform 164 (2011): 77–81.
       Link to Item
    • Tsai, Thomas T., John C. Messenger, J Matthew Brennan, Uptal D. Patel, David Dai, Robert Piana, Kevin J. Anstrom, et al. “Contemporary Risk of Follow-up Adverse Events in Older Patients with Chronic Kidney Disease and Dialysis Undergoing Percutaneous Coronary Interventions: A Report from the Merged NCDR CMS Registry.” Circulation 122, no. 21 (November 23, 2010).
       Link to Item
    • Del Fiol, Guilherme, Kensaku Kawamoto, Nancy M Allen Lapointe, Eric L. Eisenstein, Kevin J. Anstrom, Laura L. Wood, and David F. Lobach. “Improving Medication Adherence in a Regional Healthcare Information Exchange using a Scalable, Claims-Driven, and Service-Oriented Approach.” Amia Annu Symp Proc 2010 (November 13, 2010): 137–41.
       Link to Item
    • Idiopathic Pulmonary Fibrosis Clinical Research Network, Gary W., David A. Zisman, Marvin Schwarz, Kevin J. Anstrom, Harold R. Collard, Kevin R. Flaherty, and Gary W. Hunninghake. “A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.” N Engl J Med 363, no. 7 (August 12, 2010): 620–28. https://doi.org/10.1056/NEJMoa1002110.
       Full Text  Link to Item
    • Piccini, Jonathan P., Sana M. Al-Khatib, Evan R. Myers, Kevin J. Anstrom, Alfred E. Buxton, Eric D. Peterson, and Gillian D. Sanders. “Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.” J Cardiovasc Electrophysiol 21, no. 7 (July 2010): 791–98. https://doi.org/10.1111/j.1540-8167.2009.01696.x.
       Full Text  Link to Item
    • Brinkley, Jason, Anastasios Tsiatis, and Kevin J. Anstrom. “A generalized estimator of the attributable benefit of an optimal treatment regime.” Biometrics 66, no. 2 (June 2010): 512–22. https://doi.org/10.1111/j.1541-0420.2009.01282.x.
       Full Text  Link to Item
    • Eisenstein, Eric L., Emily F. Honeycutt, Kevin J. Anstrom, Richard C. Becker, Christopher B. Granger, Sunil V. Rao, Marc E. Jolicoeur, E Magnus Ohman, and E Magnus CATCH Investigators. “Economic assessment of thrombocytopenia: CATCH Registry.” J Med Syst 34, no. 3 (June 2010): 379–86. https://doi.org/10.1007/s10916-008-9250-9.
       Full Text  Link to Item
    • Wahidi, Momen M., Gerard A. Silvestri, Raymond D. Coakley, J Scott Ferguson, R Wesley Shepherd, Leonard Moses, John Conforti, et al. “A prospective multicenter study of competency metrics and educational interventions in the learning of bronchoscopy among new pulmonary fellows.” Chest 137, no. 5 (May 2010): 1040–49. https://doi.org/10.1378/chest.09-1234.
       Full Text  Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Steven E. McNulty, Greg C. Flaker, Andrew M. Tonkin, Warren M. Smith, William D. Toff, et al. “Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT).” Am Heart J 159, no. 4 (April 2010): 627-634.e7. https://doi.org/10.1016/j.ahj.2010.01.013.
       Full Text  Link to Item
    • “The IPFnet Strategy: Creating a comprehensive approach in the treatment of idiopathic pulmonary fibrosis.” Am J Respir Crit Care Med 181, no. 6 (March 15, 2010): 527–28. https://doi.org/10.1164/rccm.200903-0483ED.
       Full Text  Link to Item
    • Petersen, John L., John J. Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter M. Wahl, Eric L. Eisenstein, et al. “Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.” Am Heart J 159, no. 3 (March 2010): 462-470.e1. https://doi.org/10.1016/j.ahj.2009.11.031.
       Full Text  Link to Item
    • Allen, Larry A., Kevin J. Anstrom, John R. Horton, Linda K. Shaw, Eric L. Eisenstein, and G Michael Felker. “Relationship between anemia and health care costs in heart failure.” J Card Fail 15, no. 10 (December 2009): 843–49. https://doi.org/10.1016/j.cardfail.2009.06.435.
       Full Text  Link to Item
    • Eisenstein, Eric L., Martin B. Leon, David E. Kandzari, Laura Mauri, Rex Edwards, David F. Kong, Patricia A. Cowper, Kevin J. Anstrom, and Kevin J. ENDEAVOR III Investigators. “Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).” Jacc Cardiovasc Interv 2, no. 12 (December 2009): 1199–1207. https://doi.org/10.1016/j.jcin.2009.10.009.
       Full Text  Link to Item
    • Eisenstein, Eric L., William Wijns, Jean Fajadet, Laura Mauri, Rex Edwards, Patricia A. Cowper, David F. Kong, and Kevin J. Anstrom. “Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions).” Jacc Cardiovasc Interv 2, no. 12 (December 2009): 1178–87. https://doi.org/10.1016/j.jcin.2009.10.011.
       Full Text  Link to Item
    • Leon, Martin B., David E. Kandzari, Eric L. Eisenstein, Kevin J. Anstrom, Laura Mauri, Donald E. Cutlip, Eugenia Nikolsky, et al. “Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).” Jacc Cardiovasc Interv 2, no. 12 (December 2009): 1208–18. https://doi.org/10.1016/j.jcin.2009.10.008.
       Full Text  Link to Item
    • Lopes, Renato D., E Magnus Ohman, Christopher B. Granger, Emily F. Honeycutt, Kevin J. Anstrom, Peter B. Berger, Eric M. Crespo, et al. “Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).” Am J Cardiol 104, no. 9 (November 1, 2009): 1285–91. https://doi.org/10.1016/j.amjcard.2009.06.045.
       Full Text  Link to Item
    • DeWitt, Esi Morgan, Li Lin, Henry A. Glick, Kevin J. Anstrom, Kevin A. Schulman, and Shelby D. Reed. “Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank.” Clin Ther 31, no. 8 (August 2009): 1871–80. https://doi.org/10.1016/j.clinthera.2009.08.020.
       Full Text  Link to Item
    • Eisenstein, Eric L., Jie L. Sun, Kevin J. Anstrom, Elizabeth R. DeLong, Lynda A. Szczech, and Daniel B. Mark. “Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.” J Med Syst 33, no. 4 (August 2009): 287–97. https://doi.org/10.1007/s10916-008-9190-4.
       Full Text  Link to Item
    • Jolicoeur, E Marc, E Magnus Ohman, Emily Honeycutt, Richard C. Becker, Eric M. Crespo, Gustavo B. F. Oliveira, David J. Moliterno, Kevin J. Anstrom, and Christopher B. Granger. “Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.” Am J Cardiol 104, no. 2 (July 15, 2009): 292–97. https://doi.org/10.1016/j.amjcard.2009.03.034.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Judith A. Stafford, Paul A. Pappas, Sana M. Al-Khatib, and Kevin J. Anstrom. “Use of beta-blockers in patients with an implantable cardioverter defibrillator.” Ann Pharmacother 43, no. 7 (July 2009): 1189–96. https://doi.org/10.1345/aph.1M140.
       Full Text  Link to Item
    • Kramer, J. M., L. H. Curtis, C. S. Dupree, A. F. Hernandez, M. Massing, and K. J. Anstrom. “Eligibility criteria for β-blockade might have to be taken into account - Reply.” Archives of Internal Medicine 169, no. 11 (June 8, 2009): 1078.
    • Allen LaPointe, Nancy M., Yi Zhou, Judith A. Stafford, Adrian F. Hernandez, Judith M. Kramer, and Kevin J. Anstrom. “Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.” Am J Cardiol 103, no. 11 (June 1, 2009): 1518–24. https://doi.org/10.1016/j.amjcard.2009.01.363.
       Full Text  Link to Item
    • Douglas, Pamela S., J Matthew Brennan, Kevin J. Anstrom, Art Sedrakyan, Eric L. Eisenstein, Ghazala Haque, David Dai, et al. “Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry.” J Am Coll Cardiol 53, no. 18 (May 5, 2009): 1629–41. https://doi.org/10.1016/j.jacc.2009.03.005.
       Full Text  Link to Item
    • Eisenstein, E. L., M. B. Leon, D. E. Kandzari, R. Edwards, P. A. Cowper, D. F. Kong, M. D. Silverstein, D. B. Mark, and K. J. Anstrom. “ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL.” Value in Health 12, no. 3 (May 1, 2009): A152–A152.
       Link to Item
    • Eisenstein, E. L., R. Edwards, P. A. Cowper, D. F. Kong, M. D. Silverstein, D. B. Mark, K. J. Anstrom, and W. Wijns. “ECONOMIC ANALYSIS OF THE ENDEAVOR DRUG-ELUTING STENT VS. THE DRIVER BARE METAL STENT: RESULTS FROM THE ENDEAVOR II TRIAL.” Value in Health 12, no. 3 (May 1, 2009): A152–A152.
       Link to Item
    • Mark, Daniel B., J David Knight, Eric J. Velazquez, Jonathan G. Howlett, John A. Spertus, Ljubomir T. Djokovic, Tina M. Harding, et al. “Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.” Am Heart J 157, no. 5 (May 2009): 837-844.e3. https://doi.org/10.1016/j.ahj.2009.03.008.
       Full Text  Link to Item
    • Reed, Shelby D., Yanhong Li, Kevin J. Anstrom, and Kevin A. Schulman. “Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.” J Clin Oncol 27, no. 13 (May 1, 2009): 2185–91. https://doi.org/10.1200/JCO.2008.19.6352.
       Full Text  Link to Item
    • Crespo, Eric M., Gustavo B. F. Oliveira, Emily F. Honeycutt, Richard C. Becker, Peter B. Berger, David J. Moliterno, Kevin J. Anstrom, et al. “Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.” Am Heart J 157, no. 4 (April 2009): 651–57. https://doi.org/10.1016/j.ahj.2009.01.005.
       Full Text  Link to Item
    • Allen, Larry A., Kevin J. Anstrom, John Horton, Linda K. Shaw, Eric L. Eisenstein, and G Michael Felker. “Relationship Between Anemia Status and Health Care Costs in Patients With Symptomatic Heart Failure.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A391–A391.
       Link to Item
    • Brennan, J Matthew, Kevin J. Anstrom, Eric L. Eisenstein, David Dai, Ghazala Haque, David F. Kong, Ralph G. Brindis, et al. “Long-Term Outcomes of Drug-Eluting Versus Bare-Metal Stents in Underrepresented Populations: Results From the Linked NCDR and CMS Database.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A386–A386.
       Link to Item
    • Petersen, John L., John D. Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter M. Wahl, Eric J. Eisenstein, et al. “Clopidogrel Use and Clinical Events After Drug-Eluting Stent Implantation: Findings From the HealthCore Integrated Research Database.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A11–12.
       Link to Item
    • Mark, Daniel B., Wenqin Pan, Nancy E. Clapp-Channing, Kevin J. Anstrom, John R. Ross, Rebecca S. Fox, Gerard P. Devlin, et al. “Quality of life after late invasive therapy for occluded arteries.” N Engl J Med 360, no. 8 (February 19, 2009): 774–83. https://doi.org/10.1056/NEJMoa0805151.
       Full Text  Link to Item
    • Eisenstein, Eric L., Jie L. Sun, Kevin J. Anstrom, Judith A. Stafford, Lynda A. Szczech, Lawrence H. Muhlbaier, and Daniel B. Mark. “Do income level and race influence survival in patients receiving hemodialysis?” Am J Med 122, no. 2 (February 2009): 170–80. https://doi.org/10.1016/j.amjmed.2008.08.025.
       Full Text  Link to Item
    • Eisenstein, Eric L., David F. Lobach, Kensaku Kawamoto, Rex Edwards, Janese M. Willis, Garry M. Silvey, and Kevin J. Anstrom. “A randomized clinical trial of clinical decision support in a rural community health network serving lower income individuals: study design and baseline characteristics.” Stud Health Technol Inform 143 (2009): 220–26.
       Link to Item
    • Kramer, Judith M., Lesley H. Curtis, Carla S. Dupree, David Pelter, Adrian Hernandez, Mark Massing, and Kevin J. Anstrom. “Comparative effectiveness of beta-blockers in elderly patients with heart failure.” Arch Intern Med 168, no. 22 (December 8, 2008): 2422–28. https://doi.org/10.1001/archinternmed.2008.511.
       Full Text  Link to Item
    • Eisenstein, E. L., M. Ortiz, K. J. Anstrom, and D. F. Lobach. “Health information technology economic evaluation,” December 1, 2008, 240–58. https://doi.org/10.4018/978-1-59904-792-8.ch014.
       Full Text
    • Eisenstein, Eric L., Jie L. Sun, Kevin J. Anstrom, Judith A. Stafford, Lynda A. Szczech, Lawrence H. Muhlbaier, and Daniel B. Mark. “Re-evaluating the volume-outcome relationship in hemodialysis patients.” Health Policy 88, no. 2–3 (December 2008): 317–25. https://doi.org/10.1016/j.healthpol.2008.03.017.
       Full Text  Link to Item
    • Lobach, David F., Garry M. Silvey, Janese M. Willis, Kevin R. Kooy, Kensaku Kawamoto, Kevin J. Anstrom, Eric L. Eisenstein, and Fredrick Johnson. “Coupling direct collection of health risk information from patients through kiosks with decision support for proactive care management.” Amia Annu Symp Proc, November 6, 2008, 429–33.
       Link to Item
    • Eisenstein, E. L., P. A. Cowper, J. P. Bae, D. F. Kong, K. Ramaswamy, and K. J. Anstrom. “CV1 WHAT IS THE CLINICAL BENEFIT OF PREVENTING NON-FATAL MYOCARDIAL INFARCTIONS?” Value in Health 11, no. 6 (November 2008): A341–42. https://doi.org/10.1016/s1098-3015(10)66185-2.
       Full Text
    • Lopes, Renato D., Christopher B. Granger, Emily F. Honeycutt, Eric M. Crespo, Kevin J. Anstrom, E Magnus Ohman, and Richard C. Becker. “Patients with Thrombocytopenia following Heparin Therapy Have Early but not Late Risk of Death: Results from the CATCH Registry.” Circulation 118, no. 18 (October 28, 2008): S1052–S1052.
       Link to Item
    • Patel, Manesh R., Kevin J. Anstrom, Eric L. Eisenstein, Ralph G. Brindis, Eric D. Peterson, and Pamela S. Douglas. “Patients without obstructive coronary artery disease and stress test results: An analysis from the National Cardiovascular Data Registry.” Circulation 118, no. 18 (October 28, 2008): S1085–S1085.
       Link to Item
    • Mark, Daniel B., J David Knight, Patricia A. Cowper, Linda Davidson-Ray, and Kevin J. Anstrom. “Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.” Am Heart J 156, no. 4 (October 2008): 698–705. https://doi.org/10.1016/j.ahj.2008.05.032.
       Full Text  Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Jie L. Sun, Nancy E. Clapp-Channing, Anastasios A. Tsiatis, Linda Davidson-Ray, Kerry L. Lee, Gust H. Bardy, and Gust H. Sudden Cardiac Death in Heart Failure Trial Investigators. “Quality of life with defibrillator therapy or amiodarone in heart failure.” N Engl J Med 359, no. 10 (September 4, 2008): 999–1008. https://doi.org/10.1056/NEJMoa0706719.
       Full Text  Link to Item
    • Reed, Shelby D., Kevin J. Anstrom, Damon M. Seils, Robert M. Califf, and Kevin A. Schulman. “Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs.” Health Aff (Millwood) 27, no. 5 (September 2008): w360–70. https://doi.org/10.1377/hlthaff.27.5.w360.
       Full Text  Link to Item
    • Anstrom, Kevin J., David F. Kong, Linda K. Shaw, Robert M. Califf, Judith M. Kramer, Eric D. Peterson, Sunil V. Rao, et al. “Long-term clinical outcomes following coronary stenting.” Arch Intern Med 168, no. 15 (August 11, 2008): 1647–55. https://doi.org/10.1001/archinte.168.15.1647.
       Full Text  Link to Item
    • Olsen, E. A., V. Callender, L. Sperling, A. McMichael, K. J. Anstrom, W. Bergfeld, F. Durden, J. Roberts, J. Shapiro, and D. A. Whiting. “Central scalp alopecia photographic scale in African American women.” Dermatol Ther 21, no. 4 (July 2008): 264–67. https://doi.org/10.1111/j.1529-8019.2008.00208.x.
       Full Text  Link to Item
    • Felker, G Michael, Kevin J. Anstrom, and Joseph G. Rogers. “A global ranking approach to end points in trials of mechanical circulatory support devices.” J Card Fail 14, no. 5 (June 2008): 368–72. https://doi.org/10.1016/j.cardfail.2008.01.009.
       Full Text  Link to Item
    • Glickman, Seth W., Kevin J. Anstrom, Li Lin, Abhinav Chandra, Daniel T. Laskowitz, Christopher W. Woods, Debra H. Freeman, et al. “Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research.” Ann Emerg Med 51, no. 6 (June 2008): 775-780.e3. https://doi.org/10.1016/j.annemergmed.2007.11.002.
       Full Text  Link to Item
    • Grant, W. C., and K. J. Anstrom. “Minimizing selection bias in randomized trials: A Nash equilibrium approach to optimal randomization.” Journal of Economic Behavior and Organization 66, no. 3–4 (June 1, 2008): 606–24. https://doi.org/10.1016/j.jebo.2006.07.001.
       Full Text
    • Mankad, Vaishali S., Larry W. Williams, Laurie A. Lee, Ginger S. LaBelle, Kevin J. Anstrom, and A Wesley Burks. “Safety of open food challenges in the office setting.” Ann Allergy Asthma Immunol 100, no. 5 (May 2008): 469–74. https://doi.org/10.1016/S1081-1206(10)60473-5.
       Full Text  Link to Item
    • Konstance, Richard P., Eric L. Eisenstein, Kevin J. Anstrom, Linda K. Shaw, Robert M. Califf, Robert A. Harrington, David B. Matchar, Kevin A. Schulman, and David F. Kong. “Outcomes of second revascularization procedures after stent implantation.” J Med Syst 32, no. 2 (April 2008): 177–86. https://doi.org/10.1007/s10916-007-9120-x.
       Full Text  Link to Item
    • Curtis, Lesley H., David J. Whellan, Bradley G. Hammill, Adrian F. Hernandez, Kevin J. Anstrom, Alisa M. Shea, and Kevin A. Schulman. “Incidence and prevalence of heart failure in elderly persons, 1994-2003.” Arch Intern Med 168, no. 4 (February 25, 2008): 418–24. https://doi.org/10.1001/archinternmed.2007.80.
       Full Text  Link to Item
    • Oliveira, Gustavo B. F., Eric M. Crespo, Richard C. Becker, Emily F. Honeycutt, Charles S. Abrams, Kevin J. Anstrom, Peter B. Berger, et al. “Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.” Arch Intern Med 168, no. 1 (January 14, 2008): 94–102. https://doi.org/10.1001/archinternmed.2007.65.
       Full Text  Link to Item
    • Curtis, Lesley H., Bradley G. Hammill, M Angelyn Bethel, Kevin J. Anstrom, Lawrence Liao, John S. Gottdiener, and Kevin A. Schulman. “Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study.” Curr Med Res Opin 24, no. 1 (January 2008): 41–50. https://doi.org/10.1185/030079908x253573.
       Full Text  Link to Item
    • Reed, Shelby D., Kevin J. Anstrom, Yanhong Li, and Kevin A. Schulman. “Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.” Pharmacoeconomics 26, no. 5 (2008): 435–46. https://doi.org/10.2165/00019053-200826050-00007.
       Full Text  Link to Item
    • Green, Todd D., Virginia S. LaBelle, Pamela H. Steele, Edwin H. Kim, Laurie A. Lee, Vaishali S. Mankad, Larry W. Williams, Kevin J. Anstrom, and A Wesley Burks. “Clinical characteristics of peanut-allergic children: recent changes.” Pediatrics 120, no. 6 (December 2007): 1304–10. https://doi.org/10.1542/peds.2007-0350.
       Full Text  Link to Item
    • Lobach, D. F., K. Kawamoto, K. J. Anstrom, M. L. Russell, P. Woods, and D. Smith. “Development, deployment and usability of a point-of-care decision support system for chronic disease management using the recently-approved HL7 decision support service standard.” Studies in Health Technology and Informatics 129 (December 1, 2007): 861–65.
    • Jollis, James G., Mayme L. Roettig, Akinyele O. Aluko, Kevin J. Anstrom, Robert J. Applegate, Joseph D. Babb, Peter B. Berger, et al. “Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction.” Jama 298, no. 20 (November 28, 2007): 2371–80. https://doi.org/10.1001/jama.298.20.joc70124.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Laura Governale, Jerry Watkins, Jyotsna Mulgund, and Kevin J. Anstrom. “Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.” Am Heart J 154, no. 5 (November 2007): 893–98. https://doi.org/10.1016/j.ahj.2007.06.035.
       Full Text  Link to Item
    • Williams, Jason E., Kevin J. Anstrom, Joëlle Y. Friedman, and Kevin A. Schulman. “Racial/ethnic variation in perceptions of medical information sources in Durham County, North Carolina.” N C Med J 68, no. 6 (November 2007): 391–98.
       Link to Item
    • Eisenstein, Eric L., David F. Lobach, Paul Montgomery, Kensaku Kawamoto, and Kevin J. Anstrom. “Evaluating implementation fidelity in health information technology interventions.” Amia Annu Symp Proc, October 11, 2007, 211–15.
       Link to Item
    • Eisenstein, Eric L., David F. Lobach, Paul Montgomery, Kensaku Kawamoto, and Kevin J. Anstrom. “Implementation fidelity: a framework for evaluation in the health information technology field.” Amia Annu Symp Proc, October 11, 2007, 949.
       Link to Item
    • Kawamoto, Kensaku, Nancy M. Allen LaPointe, Garry M. Silvey, Kevin J. Anstrom, Eric L. Eisenstein, and David F. Lobach. “Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data.” Amia Annu Symp Proc, October 11, 2007, 394–98.
       Link to Item
    • Lobach, David F., Kensaku Kawamoto, Kevin J. Anstrom, Kevin R. Kooy, Eric L. Eisenstein, Garry M. Silvey, Janese M. Willis, Frederick Johnson, and Jessica Simo. “Proactive population health management in the context of a regional health information exchange using standards-based decision support.” Amia Annu Symp Proc, October 11, 2007, 473–77.
       Link to Item
    • Silvey, Garry M., Susanne B. Haga, Julianne M. O’Daniel, Patricia Deverka, Dania M. Ermentrout, Kevin J. Anstrom, and David F. Lobach. “Determining user preferences between touch and pen data entry methods in the Tablet PC computing environment.” Amia Annu Symp Proc, October 11, 2007, 1115.
       Link to Item
    • Curtis, Lesley H., Bradley G. Hammill, Eric L. Eisenstein, Judith M. Kramer, and Kevin J. Anstrom. “Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.” Med Care 45, no. 10 Supl 2 (October 2007): S103–7. https://doi.org/10.1097/MLR.0b013e31806518ac.
       Full Text  Link to Item
    • Curtis, Lesley H., Bradley G. Hammill, M Angelyn Bethel, Kevin J. Anstrom, John S. Gottdiener, and Kevin A. Schulman. “Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study.” Diabetes Care 30, no. 10 (October 2007): 2553–58. https://doi.org/10.2337/dc07-0460.
       Full Text  Link to Item
    • DePuy, Venita, Kevin J. Anstrom, Liana D. Castel, Kevin A. Schulman, Kevin P. Weinfurt, and Fred Saad. “Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.” Support Care Cancer 15, no. 7 (July 2007): 869–76. https://doi.org/10.1007/s00520-006-0203-x.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Judith A. Stafford, and Kevin J. Anstrom. “Use of antiarrhythmic drugs and beta-blockers in patients with an implantable cardioverter defibrillator.” Circulation 115, no. 21 (May 29, 2007): E596–E596.
       Link to Item
    • Curtis, L. H., B. G. Hammill, M. A. Bethel, K. J. Anstrom, J. S. Gottdiener, and K. A. Schulman. “OB2 THE COST OF THE METABOLIC SYNDROME IN THE ELDERLY: FINDINGS FROM THE CARDIOVASCULAR HEALTH STUDY.” Value in Health 10, no. 3 (May 2007): A19–A19. https://doi.org/10.1016/s1098-3015(10)68591-9.
       Full Text
    • Reed, S. D., K. J. Anstrom, Y. Li, and K. A. Schulman. “CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA.” Value in Health 10, no. 3 (May 2007): A12–A12. https://doi.org/10.1016/s1098-3015(10)68568-3.
       Full Text
    • Eisenstein, Eric L., David F. Kong, Kevin J. Anstrom, and Robert M. Califf. “Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation—Reply.” Jama 297, no. 16 (April 25, 2007): 1769–1769. https://doi.org/10.1001/jama.297.16.1770-c.
       Full Text
    • Alexander, Barbara D., Terry C. Byrne, Kelly L. Smith, Kimberly E. Hanson, Kevin J. Anstrom, John R. Perfect, and L Barth Reller. “Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.” J Clin Microbiol 45, no. 3 (March 2007): 698–706. https://doi.org/10.1128/JCM.01840-06.
       Full Text  Link to Item
    • Collard, Harold R., Kevin J. Anstrom, Marvin I. Schwarz, and David A. Zisman. “Sildenafil improves walk distance in idiopathic pulmonary fibrosis.” Chest 131, no. 3 (March 2007): 897–99. https://doi.org/10.1378/chest.06-2101.
       Full Text  Link to Item
    • Kansagra, Susan M., Lesley H. Curtis, Kevin J. Anstrom, and Kevin A. Schulman. “Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001.” Am J Cardiol 99, no. 3 (February 1, 2007): 339–43. https://doi.org/10.1016/j.amjcard.2006.08.037.
       Full Text  Link to Item
    • Liao, Lawrence, Kevin J. Anstrom, John S. Gottdiener, Paul A. Pappas, David J. Whellan, Dalane W. Kitzman, Gerard P. Aurigemma, Daniel B. Mark, Kevin A. Schulman, and James G. Jollis. “Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study.” Am Heart J 153, no. 2 (February 2007): 245–52. https://doi.org/10.1016/j.ahj.2006.11.010.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kevin J. Anstrom, David F. Kong, Linda K. Shaw, Robert H. Tuttle, Daniel B. Mark, Judith M. Kramer, et al. “Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.” Jama 297, no. 2 (January 10, 2007): 159–68. https://doi.org/10.1001/jama.297.2.joc60179.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Paul Pappas, Patricia Deverka, and Kevin J. Anstrom. “Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions.” J Gen Intern Med 22, no. 1 (January 2007): 98–101. https://doi.org/10.1007/s11606-007-0109-4.
       Full Text  Link to Item
    • Lobach, David F., Kensaku Kawamoto, Kevin J. Anstrom, Michael L. Russell, Peter Woods, and Dwight Smith. “Development, deployment and usability of a point-of-care decision support system for chronic disease management using the recently-approved HL7 decision support service standard.” Stud Health Technol Inform 129, no. Pt 2 (2007): 861–65.
       Link to Item
    • Eisenstein, E. L., E. F. Honeycutt, K. J. Anstrom, C. B. Granger, R. C. Becker, and E. M. Ohman. “PHM3 HEPARIN-RELATED THROMBOCYTOPENIA ASSOCIATED WITH MAJOR INCREASE IN HOSPITAL COSTS.” Value in Health 9, no. 6 (November 2006): A248–A248. https://doi.org/10.1016/s1098-3015(10)63347-5.
       Full Text
    • Eisenstein, E. L., R. H. Tuttle, L. K. Shaw, K. J. Anstrom, and D. F. Kong. “PCV5 DRUG-ELUTING STENT USE IS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN LONG-TERM CLINICAL OUTCOMES.” Value in Health 9, no. 6 (November 2006): A338–A338. https://doi.org/10.1016/s1098-3015(10)63622-4.
       Full Text
    • Kramer, Judith M., Bradley Hammill, Kevin J. Anstrom, Donald Fetterolf, Richard Snyder, John P. Charde, Barbara S. Hoffman, Nancy Allen LaPointe, and Eric Peterson. “National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.” Am Heart J 152, no. 3 (September 2006): 454.e1-454.e8. https://doi.org/10.1016/j.ahj.2006.02.030.
       Full Text  Link to Item
    • Mark, Daniel B., Charlotte L. Nelson, Kevin J. Anstrom, Sana M. Al-Khatib, Anastasios A. Tsiatis, Patricia A. Cowper, Nancy E. Clapp-Channing, et al. “Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).” Circulation 114, no. 2 (July 11, 2006): 135–42. https://doi.org/10.1161/CIRCULATIONAHA.105.581884.
       Full Text  Link to Item
    • Weinfurt, K. P., K. J. Anstrom, L. D. Castel, K. A. Schulman, and F. Saad. “Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.” Ann Oncol 17, no. 6 (June 2006): 986–89. https://doi.org/10.1093/annonc/mdl041.
       Full Text  Link to Item
    • Benjamin, D. K., R. Schelonka, R. White, H. P. Holley, E. Bifano, J. Cummings, K. Adcock, et al. “A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.” J Perinatol 26, no. 5 (May 2006): 290–95. https://doi.org/10.1038/sj.jp.7211496.
       Full Text  Link to Item
    • Liao, Lawrence, James G. Jollis, Kevin J. Anstrom, David J. Whellan, Dalane W. Kitzman, Gerard P. Aurigemma, Daniel B. Mark, Kevin A. Schulman, and John S. Gottdiener. “Costs for heart failure with normal vs reduced ejection fraction.” Arch Intern Med 166, no. 1 (January 9, 2006): 112–18. https://doi.org/10.1001/archinte.166.1.112.
       Full Text  Link to Item
    • Eisenstein, Eric L., Maqui Ortiz, Kevin J. Anstrom, David R. Crosslin, and David F. Lobach. “Assessing the quality of medical information technology economic evaluations: room for improvement.” Amia Annu Symp Proc, 2006, 234–38.
       Link to Item
    • Eisenstein, Eric L., Maqui Ortiz, Kevin J. Anstrom, David R. Crosslin, and David F. Lobach. “Economic evaluation in medical information technology: why the numbers don't add up.” Amia Annu Symp Proc, 2006, 914.
       Link to Item
    • Lobach, David F., Janese M. Willis, Jennifer M. Macri, Jessica Simo, and Kevin J. Anstrom. “Perceptions of Medicaid beneficiaries regarding the usefulness of accessing personal health information and services through a patient Internet portal.” Amia Annu Symp Proc, 2006, 509–13.
       Link to Item
    • Willis, Janese M., Jennifer M. Macri, Jessica Simo, Kevin J. Anstrom, and David F. Lobach. “Perceptions about use of a patient Internet portal among Medicaid beneficiaries.” Amia Annu Symp Proc, 2006, 1145.
       Link to Item
    • Cabell, Christopher H., Elias Abrutyn, Vance G. Fowler, Bruno Hoen, Jose M. Miro, G Ralph Corey, Lars Olaison, et al. “Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database.” Am Heart J 150, no. 5 (November 2005): 1092–98. https://doi.org/10.1016/j.ahj.2005.03.057.
       Full Text  Link to Item
    • Wang, Andrew, Paul Pappas, Kevin J. Anstrom, Elias Abrutyn, Vance G. Fowler, Bruno Hoen, Jose M. Miro, et al. “The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort.” Am Heart J 150, no. 5 (November 2005): 1086–91. https://doi.org/10.1016/j.ahj.2005.01.023.
       Full Text  Link to Item
    • Matchar, D. B., M. B. Patwardhan, and G. P. Samsa. “Improving adherence with clinical guidelines,” August 21, 2005, 475–89. https://doi.org/10.4324/9781410615626.
       Full Text
    • Friedman, Joëlle Y., Kevin J. Anstrom, Kevin P. Weinfurt, Mary McIntosh, Hayden B. Bosworth, Eugene Z. Oddone, Cedric M. Bright, and Kevin A. Schulman. “Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samples.” N C Med J 66, no. 4 (July 2005): 267–75.
       Link to Item
    • Fowler, Vance G., Jose M. Miro, Bruno Hoen, Christopher H. Cabell, Elias Abrutyn, Ethan Rubinstein, G Ralph Corey, et al. “Staphylococcus aureus endocarditis: a consequence of medical progress.” Jama 293, no. 24 (June 22, 2005): 3012–21. https://doi.org/10.1001/jama.293.24.3012.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Kevin J. Anstrom, Eric L. Eisenstein, Eric D. Peterson, James G. Jollis, Daniel B. Mark, Yun Li, Christopher M. O’Connor, Linda K. Shaw, and Robert M. Califf. “Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.” Ann Intern Med 142, no. 8 (April 19, 2005): 593–600. https://doi.org/10.7326/0003-4819-142-8-200504190-00007.
       Full Text  Link to Item
    • Reed, Shelby D., Kevin J. Anstrom, Ameet Bakhai, Andrew H. Briggs, Robert M. Califf, David J. Cohen, Michael F. Drummond, et al. “Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.” Am Heart J 149, no. 3 (March 2005): 434–43. https://doi.org/10.1016/j.ahj.2004.11.001.
       Full Text  Link to Item
    • Ohman, E Magnus, Christopher B. Granger, Lawrence Rice, Charles S. Abrams, Richard C. Becker, Peter B. Berger, Neal S. Kleiman, et al. “Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.” J Thromb Thrombolysis 19, no. 1 (February 2005): 11–19. https://doi.org/10.1007/s11239-005-0850-7.
       Full Text  Link to Item
    • Reed, Shelby D., Joëlle Y. Friedman, John J. Engemann, Robert I. Griffiths, Kevin J. Anstrom, Keith S. Kaye, Martin E. Stryjewski, et al. “Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.” Infect Control Hosp Epidemiol 26, no. 2 (February 2005): 175–83. https://doi.org/10.1086/502523.
       Full Text  Link to Item
    • Eisenstein, Eric L., Kevin J. Anstrom, Jennifer M. Macri, David R. Crosslin, Frederick S. Johnson, Kensaku Kawamoto, and David F. Lobach. “Assessing the potential economic value of health information technology interventions in a community-based health network.” Amia Annu Symp Proc, 2005, 221–25.
       Link to Item
    • Eisenstein, Eric L., Kevin J. Anstrom, Jennifer M. Macri, David R. Crosslin, Frederick S. Johnson, Kensaku Kawamoto, and David F. Lobach. “Developing a framework for conducting economic evaluations of community-based health information technology interventions.” Amia Annu Symp Proc, 2005, 948.
       Link to Item
    • Anstrom, Kevin J., Shelby D. Reed, Andrew S. Allen, G Alastair Glendenning, and Kevin A. Schulman. “Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.” Cancer 101, no. 11 (December 1, 2004): 2584–92. https://doi.org/10.1002/cncr.20674.
       Full Text  Link to Item
    • Reed, Shelby D., Kevin J. Anstrom, Jennifer A. Ludmer, G Alastair Glendenning, and Kevin A. Schulman. “Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.” Cancer 101, no. 11 (December 1, 2004): 2574–83. https://doi.org/10.1002/cncr.20694.
       Full Text  Link to Item
    • Chu, Vivian H., Christopher H. Cabell, Elias Abrutyn, G Ralph Corey, Bruno Hoen, Jose M. Miro, Lars Olaison, et al. “Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database.” Clin Infect Dis 39, no. 10 (November 15, 2004): 1527–30. https://doi.org/10.1086/424878.
       Full Text  Link to Item
    • Weinfurt, K. P., K. J. Anstrom, L. D. Castel, J. Brandman, and K. A. Schulman. “Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 4680.
       Link to Item
    • Shi, Li-Hong, Donald J. Woodward, Fei Luo, Kristin Anstrom, Timothy Schallert, and Jing-Yu Chang. “High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions.” Brain Res 1013, no. 1 (July 2, 2004): 98–106. https://doi.org/10.1016/j.brainres.2004.03.053.
       Full Text  Link to Item
    • Anstrom, Kristin, Dwight Bergles, Katherine Bradley, Yuqing Cao, Laurie Cestnick, Susi Lee, Erika Piedras-Rentería, Kelly Savoie, and Stephen M. Smith. “15th Annual Spring Brain Conference, March 10-13, 2004, summary report.” Somatosens Mot Res 21, no. 2 (June 2004): 137–43. https://doi.org/10.1080/08990220410001721284.
       Full Text  Link to Item
    • Liao, Lawrence, Christopher H. Cabell, James G. Jollis, Eric J. Velazquez, William T. Smith, Kevin J. Anstrom, Paul A. Pappas, Thomas Ryan, Joseph A. Kisslo, and Carolyn K. Landolfo. “Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization.” Am J Cardiol 93, no. 10 (May 15, 2004): 1275–79. https://doi.org/10.1016/j.amjcard.2004.01.071.
       Full Text  Link to Item
    • Curtis, Lesley H., Amy W. Law, Kevin J. Anstrom, and Kevin A. Schulman. “The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey.” Med Care 42, no. 5 (May 2004): 439–46. https://doi.org/10.1097/01.mlr.0000124247.03660.09.
       Full Text  Link to Item
    • Guller, Ulrich, Kevin J. Anstrom, William L. Holman, Richard M. Allman, Monique Sansom, and Eric D. Peterson. “Outcomes of early extubation after bypass surgery in the elderly.” Ann Thorac Surg 77, no. 3 (March 2004): 781–88. https://doi.org/10.1016/j.athoracsur.2003.09.059.
       Full Text  Link to Item
    • Cabell, Christopher H., Benjamin H. Trichon, Eric J. Velazquez, Jean G. Dumesnil, Kevin J. Anstrom, Thomas Ryan, Alan B. Miller, et al. “Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study.” Am Heart J 147, no. 1 (January 2004): 151–57. https://doi.org/10.1016/j.ahj.2003.07.010.
       Full Text  Link to Item
    • Trichon, Benjamin H., Donald D. Glower, Linda K. Shaw, Christopher H. Cabell, Kevin J. Anstrom, G Michael Felker, and Christopher M. O’Connor. “Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation.” Circulation 108 Suppl 1 (September 9, 2003): II103–10. https://doi.org/10.1161/01.cir.0000087656.10829.df.
       Full Text  Link to Item
    • McGuire, Darren K., Kevin J. Anstrom, and Eric D. Peterson. “Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database.” Circulation 107, no. 14 (April 15, 2003): 1864–70. https://doi.org/10.1161/01.CIR.0000064901.21619.01.
       Full Text  Link to Item
    • Eisenstein, Eric L., Linda K. Shaw, Charlotte L. Nelson, Kevin J. Anstrom, Zafar Hakim, and Daniel B. Mark. “Obesity and long-term clinical and economic outcomes in coronary artery disease patients.” Obes Res 10, no. 2 (February 2002): 83–91. https://doi.org/10.1038/oby.2002.14.
       Full Text  Link to Item
    • Anstrom, K. J., and A. A. Tsiatis. “Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data.” Biometrics 57, no. 4 (December 2001): 1207–18. https://doi.org/10.1111/j.0006-341x.2001.01207.x.
       Full Text  Link to Item
    • Peterson, E. D., A. J. Lansky, J. Kramer, K. Anstrom, M. J. Lanzilotta, and M. J. National Cardiovascular Network Clinical Investigators. “Effect of gender on the outcomes of contemporary percutaneous coronary intervention.” Am J Cardiol 88, no. 4 (August 15, 2001): 359–64. https://doi.org/10.1016/s0002-9149(01)01679-4.
       Full Text  Link to Item
    • Eisenstein, E. L., L. K. Shaw, K. J. Anstrom, C. L. Nelson, Z. Hakim, V. Hasselblad, and D. B. Mark. “Assessing the clinical and economic burden of coronary artery disease: 1986-1998.” Med Care 39, no. 8 (August 2001): 824–35. https://doi.org/10.1097/00005650-200108000-00008.
       Full Text  Link to Item
    • Sashihara, T., M. Dan, H. Kimura, H. Matsusaki, K. Sonomoto, and A. Ishizaki. “The effect of osmotic stress on the production of nukacin ISK-1 from Staphylococcus warneri ISK-1.” Appl Microbiol Biotechnol 56, no. 3–4 (August 2001): 496–501. https://doi.org/10.1007/s002530100669.
       Full Text  Link to Item
    • Holman, W. L., R. M. Allman, M. Sansom, C. I. Kiefe, E. D. Peterson, K. J. Anstrom, S. S. Sankey, S. G. Hubbard, R. G. Sherrill, and R. G. Alabama CABG Study Group. “Alabama coronary artery bypass grafting project: results of a statewide quality improvement initiative.” Jama 285, no. 23 (June 20, 2001): 3003–10. https://doi.org/10.1001/jama.285.23.3003.
       Full Text  Link to Item
    • Mast, S. T., K. R. Gersing, K. J. Anstrom, K. R. Krishnan, R. M. Califf, and J. G. Jollis. “Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation.” Am J Cardiol 87, no. 8 (April 15, 2001): 989-93:A4. https://doi.org/10.1016/s0002-9149(01)01435-7.
       Full Text  Link to Item
    • Mast, S. T., J. G. Jollis, T. Ryan, K. J. Anstrom, and J. L. Crary. “The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.” Ann Intern Med 134, no. 4 (February 20, 2001): 261–66. https://doi.org/10.7326/0003-4819-134-4-200102200-00008.
       Full Text  Link to Item
    • Eisenstein, E. L., L. K. Shaw, C. L. Nelson, K. J. Anstrom, Z. Hakim, and D. B. Mark. “Assessing the relationship between obesity and long-term clinical and economic outcomes in coronary artery disease patients.” Journal of the American College of Cardiology 37, no. 2 (February 1, 2001): 508A-509A.
       Link to Item
    • Batchelor, W. B., K. J. Anstrom, L. H. Muhlbaier, R. Grosswald, W. S. Weintraub, W. W. O’Neill, and E. D. Peterson. “Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration.” J Am Coll Cardiol 36, no. 3 (September 2000): 723–30. https://doi.org/10.1016/s0735-1097(00)00777-4.
       Full Text  Link to Item
    • Alexander, K. P., K. J. Anstrom, L. H. Muhlbaier, R. D. Grosswald, P. K. Smith, R. H. Jones, and E. D. Peterson. “Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network.” J Am Coll Cardiol 35, no. 3 (March 1, 2000): 731–38. https://doi.org/10.1016/s0735-1097(99)00606-3.
       Full Text  Link to Item
    • Edwards, F. H., E. R. DeLong, A. L. Shroyer, K. J. Anstrom, F. L. Grover, and E. D. Peterson. “Prediction of operative mortality following valve replacement surgery.” Journal of the American College of Cardiology 35, no. 2 (February 1, 2000): 529A-530A.
       Link to Item
    • Peterson, E. D., A. J. Lansky, K. J. Anstrom, L. H. Muhlbaier, J. J. Popma, L. F. Satler, and M. J. Lanzilotta. “Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database.” Am Heart J 139, no. 2 Pt 1 (February 2000): 198–207. https://doi.org/10.1067/mhj.2000.103848.
       Full Text  Link to Item
    • Peterson, E. D., K. J. Anstrom, and D. K. McGuire. “The influence of the BARI diabetic treatment alert on revascularization selection patterns: The NCN results.” Journal of the American College of Cardiology 35, no. 2 (February 1, 2000): 544A-544A.
       Link to Item
    • Peterson, E. D., A. J. Lansky, K. J. Anstrom, L. H. Muhlbaier, J. J. Popma, L. F. Satler, and M. J. Lanzilotta. “Evolving trends in interventional device use and outcomes: Results from the national cardiovascular network database.” American Heart Journal 139, no. 2 (January 1, 2000): 198–207. https://doi.org/10.1016/S0002-8703(00)90226-6.
       Full Text
    • Woodward, D. J., J. Y. Chang, P. Janak, A. Azarov, and K. Anstrom. “Activity patterns in mesolimbic regions in rats during operant tasks for reward.” Prog Brain Res 126 (2000): 303–22. https://doi.org/10.1016/S0079-6123(00)26021-4.
       Full Text  Link to Item
    • Anstrom, K. J., and J. G. Jollis. “Translation of clinical evidence into medical practice.” Am Heart J 138, no. 6 Pt 1 (December 1999): 1001–2. https://doi.org/10.1016/s0002-8703(99)70057-8.
       Full Text  Link to Item
    • Peterson, E. D., K. J. Anstrom, W. L. Holman, E. R. DeLong, C. I. Klefe, and R. M. Allman. “The safety of early extubation following CABG in the elderly: Results in 4,538 pts aged 65 yrs or older.” Circulation 100, no. 18 (November 2, 1999): 592–592.
       Link to Item
    • Woodward, D. J., J. Y. Chang, P. Janak, A. Azarov, and K. Anstrom. “Mesolimbic neuronal activity across behavioral states.” Ann N Y Acad Sci 877 (June 29, 1999): 91–112. https://doi.org/10.1111/j.1749-6632.1999.tb09263.x.
       Full Text  Link to Item
    • Batchelor, W. “Does Stenting Benefit the Very Elderly? An Analysis of Device-specific Outcomes in 3,740 Octogenarians.” Journal of the American College of Cardiology 31, no. 2 (February 1998): 77A-77A. https://doi.org/10.1016/s0735-1097(97)84043-0.
       Full Text
    • Jollis, J. “Mortality Following Acute Myocardial Infarction According to Physician Experience, Technical Training, and Specialty.” Journal of the American College of Cardiology 31, no. 2 (February 1998): 363A-363A. https://doi.org/10.1016/s0735-1097(97)85286-2.
       Full Text
    • Lansky, A. “Gender Differences in Device Selection and Procedural Outcome: A National Cardiovascular Network (NCN) Report.” Journal of the American College of Cardiology 31, no. 2 (February 1998): 234A-234A. https://doi.org/10.1016/s0735-1097(97)84721-3.
       Full Text

  • Book Sections

    • Willis JM, M. R., R. Edwards, K. J. Anstrom, F. S. Johnson, G. Del Fiol, K. Kawamoto, N. M. Allen lapointe, E. L. Eisenstein, and D. F. Lobach. “Decision Support for Evidence-Based Pharmacotherapy Detects Adherence Problems but Does Not Impact Medication Use.” In Enabling Health and Healthcare Through ICT, edited by Karen L. Courtney, Omid Shabestari, and Alexander Kuo, 183:116–25. IOS Press, 2013.

  • Conference Papers

    • Ezekowitz, Justin, Ciaran McMullan, Cynthia Westerhout, Ileana L. Pina, Jose Lopez-Sendon, Kevin J. Anstrom, Adrian F. Hernandez, et al. “Effect Of Vericiguat In Victoria According To Guideline-directed Medical Therapy.” In Journal of Cardiac Failure, 26:1108–9, 2020.
       Link to Item
    • Ezekowitz, Justin, Ciaran McMullan, Cynthia Westerhout, Ileana L. Pina, Jose Lopez-Sendon, Kevin J. Anstrom, Adrian F. Hernandez, et al. “Effect of Vericiguat in Victoria According to Guideline-directed Medical Therapy.” In Journal of Cardiac Failure, 26:S65–66, 2020.
       Link to Item
    • Felker, G Michael, Margaret M. Redfield, Robert J. Mentz, Mark E. Dunlap, Gregory D. Lewis, Andrew L. Smith, Steven E. McNulty, et al. “Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies.” In Journal of Cardiac Failure, 25:S75–S75. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.213.
       Full Text
    • Wan, Luxi, Christopher O’Connor, Amanda Stebbins, Brooke Alhanti, Marc D. Samsky, Haider J. Warraich, Kimberly S. Johnson, et al. “Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF.” In Journal of Cardiac Failure, 25:S154–55. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.444.
       Full Text
    • Fudim, Marat, Andrew P. Ambrosy, Jie-Lena Sun, Kevin J. Anstrom, Bradley A. Bart, Javed Butler, Omar AbouEzzeddine, et al. “High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.” In J Am Heart Assoc, 7:e010364, 2018. https://doi.org/10.1161/JAHA.118.010364.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Christopher P. Cannon, Niteesh K. Choudhry, Timothy D. Henry, Kevin J. Anstrom, et al. “The "Halo Effect" of a P2Y12 Inhibitor Copayment Reduction Intervention on Persistence and Adherence With Other Secondary Prevention Medications: Results From the ARTEMIS Cluster Randomized Clinical Trial.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Fanaroff, Alexander C., Eric D. Peterson, Lisa A. Kaltenbach, Gregg C. Fonarow, Niteesh K. Choudhry, Kevin J. Anstrom, Timothy D. Henry, et al. “Method of Assessing Medication Persistence and Clinical Outcomes: A Comparison of Patient Report and Pharmacy Fill Data From the ARTEMIS Trial.” In Circulation, Vol. 138, 2018.
       Link to Item
    • Mentz, Robert J., Christopher M. O’Connor, Bradi B. Granger, Hongqiu Yang, Chetan B. Patel, Karen E. Steinhauser, Mona Fiuzat, et al. “Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial.” In Am Heart J, 204:202–4, 2018. https://doi.org/10.1016/j.ahj.2018.07.010.
       Full Text  Link to Item
    • Wang, Tracy, Lisa A. Kaltenbach, Gregg C. Fonarow, Timothy D. Henry, Christopher P. Cannon, David J. Cohen, Eileen Fonseca, et al. “Assessing Longitudinal Medication Use in Pragmatic Clinical Trials: Insights From the ARTEMIS Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.
       Link to Item
    • Felker, G Michael, Kevin J. Anstrom, Kirkwood F. Adams, Justin A. Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L. Januzzi, et al. “Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” In Journal of Cardiac Failure, 23:830–830. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, 2017.
       Link to Item
    • DeVore, Adam D., Steven McNulty, Fawaz Alenezi, Mads Ersboll, Justin M. Vader, Jae K. Oh, Grace Lin, et al. “Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.” In Eur J Heart Fail, 19:893–900, 2017. https://doi.org/10.1002/ejhf.754.
       Full Text  Link to Item
    • Snipelisky, David, Jacob Kelly, James A. Levine, Gabriel A. Koepp, Kevin J. Anstrom, Steven E. McNulty, Rosita Zakeri, et al. “Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.” In Circ Heart Fail, 10:e003878, 2017. https://doi.org/10.1161/CIRCHEARTFAILURE.117.003878.
       Full Text  Link to Item
    • Butler, Javed, Marvin A. Konstam, Michael Felker, Andreas P. Kalogeropoulos, Michael M. Givertz, Douglas L. Mann, Kenneth B. Margulies, et al. “Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure (ATHENA-HF) Trial.” In Circulation, 134:E707–8. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Lewis, Gregory D., Kevin J. Anstrom, Steven McNulty, Adrian F. Hernandez, and Eugene Braunwald. “Oral Iron Repletion effects on Oxygen Uptake in Heart Failure (IRONOUT HF).” In Circulation, 134:E708–E708. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • Wang, Tracy, Lisa A. McCoy, Niteesh K. Choudhry, Timothy D. Henry, Christopher P. Cannon, Gregg C. Fonarow, Jacob A. Doll, et al. “Hospital Strategies to Address Non-Adherence to Guideline-Recommended Dual Antiplatelet Therapy After Myocardial Infarction: Findings From the Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS).” In Circulation, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.
       Link to Item
    • O’Brien, E. C., P. Shrader, M. T. Durheim, L. D. Snyder, J. L. Todd, V. Gamerman, K. J. Anstrom, et al. “Disease Severity And Quality Of Life In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients.” In American Journal of Respiratory and Critical Care Medicine, Vol. 193. AMER THORACIC SOC, 2016.
       Link to Item
    • Punjabi, N., D. Whellan, M. Fiuzat, A. Benjafield, H. Woehrle, K. J. Anstrom, A. Blase, J. Lindenfeld, O. Oldenburg, and C. O’Connor. “Cardiovascular Improvements With Adaptive Servo-Ventilation In Heart Failure: Insights From The Cat-Hf Trial.” In American Journal of Respiratory and Critical Care Medicine, Vol. 193. AMER THORACIC SOC, 2016.
       Link to Item
    • Alexander, Karen P., Kristi Prather, Kevin J. Anstrom, Daniel Mark, Ori Ben-Yehuda, Linda Davidson-Ray, Giora Weisz, Ramin Farzaneh-Far, Gregg Stone, and E Magnus Ohman. “Angina and Quality of Life Following PCI With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.” In Circulation, 132:2273–2273. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Redfield, Margaret M., Kevin J. Anstrom, James A. Levine, Barry Borlaug, Horng Chen, Martin M. LeWinter, Susan M. Joseph, et al. “Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction (NEAT-HFpEF).” In Circulation, 132:2268–2268. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • “Late-Breaking Clinical Trial Abstracts.” In Circulation, 132:2267–85. Ovid Technologies (Wolters Kluwer Health), 2015. https://doi.org/10.1161/cir.0000000000000334.
       Full Text
    • Gandhi, Parul U., Margaret M. Redfield, Horng H. Chen, Susanna R. Stevens, Kevin J. Anstrom, Hanna K. Gaggin, Marc J. Semigran, and James L. Januzzi. “Insulin-like Growth Factor-binding Protein 7 as a Biomarker of Diastolic Dysfunction and Functional Capacity: Results From the Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure With Preserved Ejection Fraction (RELAX) Trial.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Kelly, Jacob P., Robert J. Mentz, Dianne Gallup, Kevin J. Anstrom, Margaret M. Redfield, Horng H. Chen, Christopher M. O’Connor, Adrian F. Hernandez, and G Michael Felker. “Regulatory Implications of Different Definitions and Outcomes in Worsening Heart Failure.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Zeitler, Emily P., Yongfei Wang, Kumar Dharmarajan, Kevin J. Anstrom, Eric D. Peterson, James P. Daubert, Jeptha P. Curtis, and Sana M. Al-Khatib. “Outcomes Associated With Lead Abandonment versus Lead Extraction Strategies for Revision of Sterile Leads: An NCDRO (R) Analysis.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Zettler, Marjorie E., Eric D. Peterson, Lisa A. McCoy, Mark B. Effron, Kevin J. Anstrom, Timothy D. Henry, Brian A. Baker, John C. Messenger, David J. Cohen, and Tracy Y. Wang. “Switching of ADP Receptor Inhibitor After Hospital Discharge Among Myocardial Infarction Patients: Insights From the TRANSLATE-ACS Observational Study.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.
       Link to Item
    • Agada, N., R. Zhou, S. Yang, S. Zhang, K. J. Anstrom, M. Kraft, and N. Lugogo. “Clinical Markers Of Th2 Status Are Poorly Predictive In Obese Asthmatics.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Durheim, M. T., H. R. Collard, R. S. Roberts, K. K. Brown, K. R. Flaherty, T. E. King, S. M. Palmer, et al. “Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Oldham, J. M., S. -. F. Ma, R. Vij, Y. Huang, G. Raghu, K. J. Anstrom, F. J. Martinez, and I. Noth. “Genetic Heterogeneity Among Patients Enrolled In The Panther-Ipf Clinical Trial.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Yagihashi, K., D. A. Lynch, J. Huckleberry, J. Zach, S. Humphries, E. Yow, K. R. Flaherty, et al. “Quantitative CT Analysis And Survival In Idiopathic Pulmonary Fibrosis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.
       Link to Item
    • Cowper, Patricia A., Shubin Sheng, Kevin J. Anstrom, Judith A. Stafford, Renato D. Lopes, Linda Davidson-Ray, Lars Wallentin, et al. “The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group.” In Circulation, Vol. 130. LIPPINCOTT WILLIAMS & WILKINS, 2014.
       Link to Item
    • Krishnamoorthy, Arun, Eric D. Peterson, Emily F. Honeycutt, Kevin J. Anstrom, Mark B. Effron, Marjorie E. Zettler, Linda Davidson-Ray, et al. “Can We Rely on Patients to Report Rehospitalizations After Acute Myocardial Infarction? Implications for the Design of Future Practical Clinical Studies.” In Circulation, Vol. 130. LIPPINCOTT WILLIAMS & WILKINS, 2014.
       Link to Item
    • Chen, Horng H., Kevin J. Anstrom, Susanna R. Stevens, Anita Deswal, G Michael Felker, Michael M. Givertz, Bradley A. Bart, et al. “Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial.” In Journal of Cardiac Failure, 20:S94–S94. Elsevier BV, 2014. https://doi.org/10.1016/j.cardfail.2014.06.264.
       Full Text
    • Mentz, Robert J., Jonathan Buggey, Phillip J. Schulte, Adam D. DeVore, Kevin J. Anstrom, Eric L. Eisenstein, Mona Fiuzat, Christopher M. O’Connor, and Eric J. Velazquez. “Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital.” In Journal of Cardiac Failure, 20:S95–S95. Elsevier BV, 2014. https://doi.org/10.1016/j.cardfail.2014.06.267.
       Full Text
    • Testani, Jeffrey M., Susanna R. Stevens, Meredith A. Brisco, Adrian F. Hernandez, Kevin J. Anstrom, and W. H. Wilson Tang. “Influence of Diuretic Dose and Route of Administration on Loop Diuretic Efficiency: Insights from the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) Trial.” In Journal of Cardiac Failure, 20:S40–S40. Elsevier BV, 2014. https://doi.org/10.1016/j.cardfail.2014.06.115.
       Full Text
    • Raghu, G., J. DeAndrade, K. J. Anstrom, T. E. King, and F. J. Martinez. “A Double Blind, Placebo-Controlled, Randomized Trial Of N-Acetylcysteine In Idiopathic Pulmonary Fibrosis.” In American Journal of Respiratory and Critical Care Medicine, Vol. 189. AMER THORACIC SOC, 2014.
       Link to Item
    • Martinez, F. J., K. K. Brown, H. R. Collard, K. R. Flaherty, T. E. King, G. Raghu, J. Roman, M. I. Schwarz, E. Yow, and K. J. Anstrom. “Discrepancy Between Changes In FVC And Disease Progression In Two Prospective Idiopathic Pulmonary Fibrosis (ipf) Therapeutic Trials.” In American Journal of Respiratory and Critical Care Medicine, Vol. 187. AMER THORACIC SOC, 2013.
       Link to Item
    • Raghu, G., D. Mart, K. J. Anstrom, M. Hinojosa, J. Hayes, C. Spada, B. Oelschlager, and C. Pellegrini. “Treatment Of Idiopathic Pulmonary Fibrosis (ipf) With Laparoscopic Anti-Reflux Surgery (lars) Is Associated With Improvement In Forced Vital Capacity (FVC).” In American Journal of Respiratory and Critical Care Medicine, Vol. 187. AMER THORACIC SOC, 2013.
       Link to Item
    • Bart, Bradley A., Steven R. Goldsmith, Kerry L. Lee, Lynne W. Stevenson, Christopher M. O’Connor, David A. Bull, Margaret M. Redfield, et al. “Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network.” In Circulation, 126:2786–2786. LIPPINCOTT WILLIAMS & WILKINS, 2012.
       Link to Item
    • Eisenstein, Eric L., Linda Davidson-Ray, Rex Edwards, Kevin J. Anstrom, Patricia A. Cowper, Daniel B. Mark, and Thomas R. Aversano. “Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery.” In Circulation, 126:2779–2779. LIPPINCOTT WILLIAMS & WILKINS, 2012.
       Link to Item
    • Mark, Daniel B., Kevin J. Anstrom, Robin Boineau, Christine Goertz, Theodore C. Rozema, J David Knight, Nancy E. Clapp-Channing, et al. “Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT).” In Circulation, 126:2779–80. LIPPINCOTT WILLIAMS & WILKINS, 2012.
       Link to Item
    • Hillegass, William B., Manesh R. Patel, Kevin J. Anstrom, David Dai, Lloyd W. Klein, Hitinder S. Guram, Eric L. Eisenstein, Eric D. Peterson, John C. Messenger, and Pamela S. Douglas. “ACUTE AND LONG-TERM OUTCOMES IN OLDER DIABETIC PATIENTS RECEIVING A CORONARY STENT: CONTEMPORARY RESULTS IN 405,679 PATIENTS.” In Journal of the American College of Cardiology, 57:E1695–E1695. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61695-1.
       Full Text
    • Riles, Eric M., Eric L. Eisenstein, Kevin J. Anstrom, Rex Edwards, Daniel B. Mark, and Judith Hochman. “Cost-effectiveness of an Early Revascularization Strategy for Cardiogenic Shock Based on Long-term Outcomes.” In Circulation, 120:S989–S989. LIPPINCOTT WILLIAMS & WILKINS, 2009.
       Link to Item
    • Eisenstein, Eric L., Patricia A. Cowper, Jay Bae, David F. Kong, and Kevin J. Anstrom. “Assessing proportions of higher-risk acute coronary syndrome-percutaneous coronary intervention patients in clinical trials and clinical practice.” In Circulation, 117:E421–22. LIPPINCOTT WILLIAMS & WILKINS, 2008.
       Link to Item
    • Jolicoeur, Marc E., Magnus E. Ohman, Emily F. Honeycutt, Francisco J. N. Mazon, Richard C. Beckerd, Eric M. Crespo, Gustavo B. F. Oliveira, David J. Moliterno, Kevin J. Anstrom, and Christopher B. Granger. “Bleeding is common among patients treated with heparin experiencing thrombocyllopenia and confers a high mortality risk: Report from the CATCH registry.” In Journal of the American College of Cardiology, 49:340A-340A. ELSEVIER SCIENCE INC, 2007.
       Link to Item
    • Reed, Shelby D., Kevin J. Anstrom, Yanhong Li, and Kevin A. Schulman. “Updated Cost-Effectiveness Analysis of First-Line Imatinib Compared to Interferon-α in Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Chronic Phase Using 60-Month Data from IRIS.” In Blood, 108:3312–3312. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.3312.3312.
       Full Text
    • Eisenstein, Eric L., Robert M. Tuttle, Linda K. Shaw, Kevin J. Anstrom, and David F. Kong. “Drug-eluting stent use is associated with significant improvements in long-term clinical outcomes.” In Circulation, 114:863–863. LIPPINCOTT WILLIAMS & WILKINS, 2006.
       Link to Item
    • Liao, L., J. H. Alexander, D. F. Kong, M. H. Sketch, P. A. Pappas, J. Zhou, S. S. Lin, L. K. Shaw, K. J. Anstrom, and D. B. Mark. “Which patients with previous bypass surgery benefit most from repeat revascularization?” In Journal of the American College of Cardiology, 47:203A-203A. ELSEVIER SCIENCE INC, 2006.
       Link to Item
    • Oliveira, G. B., K. J. Anstrom, E. F. Honeycutt, C. S. Abrams, R. C. Becker, P. B. Berger, D. J. Moliterno, et al. “Prolonged heparin exposure, development of thrombocytopenia, use of GP IIb/IIIa inhibitors, and history of renal dysfunction predict moderate or severe bleeding: A report from the complications after thrombocytopenia caused by heparin (CATCH) registry.” In Journal of the American College of Cardiology, 47:251A-251A. ELSEVIER SCIENCE INC, 2006.
       Link to Item
    • Green, T. D., G. S. Labelle, P. H. Steele, L. A. Lee, V. S. Mankad, L. W. Williams, K. J. Anstrom, and A. W. Burks. “Clinical Characteristics of Patients with Peanut Allergy.” In Journal of Allergy and Clinical Immunology, 117:S35–S35. Elsevier BV, 2006. https://doi.org/10.1016/j.jaci.2005.12.142.
       Full Text
    • Oliveira, G. B. F., K. J. Anstrom, E. F. Honeycutt, R. C. Becker, D. J. Moliterno, S. Moll, E. M. Ohman, and C. B. Granger. “Intravenous unfractionated heparin, patient profile, and the magnitude of thrombocytopenia are associated with heparin-induced thrombocytopenia (HIT) antibodies: insights from the CATCH registry.” In European Heart Journal, 26:725–725. OXFORD UNIV PRESS, 2005.
       Link to Item
    • Mark, D. B., C. L. Nelson, K. J. Anstrom, S. M. Al-Khatib, A. A. Tsiatis, J. Poole, G. Johnson, et al. “Cost-effectiveness of ICD therapy in the sudden cardiac death in heart failure trial (SCD-HeFT).” In Circulation, 111:1727–1727. LIPPINCOTT WILLIAMS & WILKINS, 2005.
       Link to Item
    • Eisenstein, E. L., J. L. Sun, K. J. Anstrom, and D. B. Mark. “Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.” In Journal of the American College of Cardiology, 45:340A-340A. ELSEVIER SCIENCE INC, 2005.
       Link to Item
    • Ohman, E. M., C. S. Abrams, E. F. Honeycutt, R. C. Becker, E. M. Crespo, K. J. Anstrom, D. J. Moliterno, et al. “High mortality after discharge among patients with high risk for developing heparin-induced thrombocytopenia or thrombosis: 6-month follow-up results of the complications after thrombocytopenia caused by heparin (CATCH) registry.” In Journal of the American College of Cardiology, 45:411A-411A. ELSEVIER SCIENCE INC, 2005.
       Link to Item
    • Wang, A., P. Pappas, K. J. Anstrom, E. Abrutyn, V. G. Fowler, B. Hoen, J. M. Miro, et al. “The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort.” In Journal of the American College of Cardiology, 45:363A-363A. ELSEVIER SCIENCE INC, 2005.
       Link to Item
    • Moll, Stephan, Charles S. Abrams, Lawrence Rice, Richard C. Becker, Peter B. Berger, Kevin J. Anstrom, Emily F. Honeycutt, et al. “Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.” In Blood, 104:2197–2197. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.2197.2197.
       Full Text
    • Aksoy, O., H. Cabell, V. G. Fowler, A. Wang, V. Chu, P. Pappas, K. J. Anstrom, et al. “Predictors of long-term mortality in patients with infective endocarditis (IE): A propensity score analysis.” In Circulation, 110:567–567. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Crespo, E. M., R. C. Becker, P. B. Berger, S. Moll, D. J. Moliterno, L. Rice, C. S. Abrams, et al. “Evaluation and outcomes of thrombocytopenia developing while on heparin among cardiac care unit patients: Insights from the complications after thrombocytopenia caused by heparin (CATCH) registry.” In Circulation, 110:370–71. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Oliveira, G. B., K. J. Anstrom, E. F. Honeycutt, C. S. Abrams, R. C. Becker, P. B. Berger, D. J. Moliterno, et al. “Days on intravenous heparin predicts thrombocytopenia and drop platelet count on heparin predicts mortality: Findings from the complications after thrombocytopenia caused by heparin (CATCH) registry.” In Circulation, 110:559–60. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Rodgers, J. E., K. J. Anstrom, E. F. Honeycutt, C. S. Abrams, R. C. Becker, P. B. Berger, E. M. Crespo, et al. “Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry.” In Circulation, 110:371–371. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Weinfurt, K. P., K. J. Anstrom, L. D. Castel, J. Brandman, and K. A. Schulman. “Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer.” In Journal of Clinical Oncology, 22:426S-426S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Crespo, Eric M., Richard C. Becker, Peter B. Berger, Christopher B. Granger, Neal S. Kleinman, David J. Moliterno, Stephan Moll, et al. “1123-180 Incidence and evaluation of heparin-induced thrombocytopenia (HIT) among patients treated with prolonged heparin and among thrombocytopenic patients in the cardiac care unit: Preliminary results of the CATCH registry.” In Journal of the American College of Cardiology, 43:A501–A501. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)92119-5.
       Full Text
    • Reed, S. D., K. J. Anstrom, J. A. Foster, A. G. Glendening, and K. A. Schulman. “A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase.” In Blood, 102:252A-252A. AMER SOC HEMATOLOGY, 2003.
       Link to Item
    • Rice, L., C. S. Abrams, K. J. Anstrom, R. C. Becker, P. B. Berger, C. B. Granger, N. S. Kleiman, et al. “Thrombocytopenia is common among patients treated with heparin and is rarely detected and evaluated with serologic testing and hematology consultation: Preliminary findings from the CATCH registry.” In Blood, 102:537A-537A. AMER SOC HEMATOLOGY, 2003.
       Link to Item
    • Liao, L., J. G. Jollis, D. J. Whellan, A. Chen, K. J. Anstrom, D. W. Kitzman, G. P. Aurigemma, K. A. Schulman, and J. S. Gottdiener. “Differences in health care costs for systolic versus diastolic heart failure of the elderly: The cardiovascular health study.” In Circulation, 108:775–775. LIPPINCOTT WILLIAMS & WILKINS, 2003.
       Link to Item
    • Liao, L., J. S. Gottdiener, D. J. Whellan, A. Chen, K. J. Anstrom, D. W. Kitzman, G. P. Aurigemma, K. A. Schulman, and J. G. Jollis. “Total 4-year health care costs and resource use in elderly patients with congestive heart failure: The cardiovascular health study.” In Circulation, 108:756–756. LIPPINCOTT WILLIAMS & WILKINS, 2003.
       Link to Item
    • Trichon, B. H., E. J. Velazquez, J. G. Dumesnil, C. H. Cabell, K. J. Anstrom, C. M. O’Connor, C. K. Landalfo, J. G. Jollis, and T. Ryan. “Are the AHA/ACC heart failure guidelines regarding serial echocardiographic studies justified?” In Circulation, 106:646–646. LIPPINCOTT WILLIAMS & WILKINS, 2002.
       Link to Item
    • ANSTROM, K. J., and D. QUADE. “Testing whether a count variable belongs to the Katz family of distributions.” In American Statistical Association  1994 Proceedings of the Statistical Computing Section, 194–99. AMER STATISTICAL ASSOC, 1994.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.